BindingDB logo
myBDB logout

Search by Patent Identification


Patent: (prefix with "US" like US6078908)
PatentDataPatent TitleOrganizationDepositionDownloads
US9688678 176 Oxindole compounds carrying a nitrogen-bound spiro substituent and use thereof for treating vasopressin-related diseases AbbVie Deutschland GmbH & Co. KG 03/27/182D 3D TSV
US9688683 4 Substituted condensed pyrimidine compounds Dalhousie University 03/27/182D 3D TSV
US9675593 24 Anti-fibrotic pyridinones INTERMUNE, Inc. 03/16/182D 3D TSV
US9675594 4 Arylpyrrolopyridine derived compounds as LRRK2 inhibitors H. Lundbeck A/S 03/16/182D 3D TSV
US9675539 24 Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives Duke University 03/16/182D 3D TSV
US9675571 24 Inhibitors of indoleamine 2,3-dioxygenase (IDO) Bristol-Myers Squibb Company 03/16/182D 3D TSV
US9675591 24 Methods for treating seizure disorders and pain SRMLSC 03/16/182D 3D TSV
US9675605 92 Substituted naphthyridine and quinoline compounds as MAO inhibitors Dart NeuroScience (Cayman) Ltd. 03/16/182D 3D TSV
US9688642 2 Substituted pyrazines as GPR40 agonists Janssen Pharmaceutica NV 03/12/182D 3D TSV
US9688643 24 Triazine derivative and pharmaceutical composition comprising the same SHIONOGI & CO., LTD. 03/12/182D 3D TSV
US9682995 600 Amino-substituted isothiazoles BAYER PHARMA AKTIENGESELLSCHAFT 03/10/182D 3D TSV
US9682993 600 Anticancer compounds St. Jude Children's Research Hospital 03/10/182D 3D TSV
US9682983 600 BMP inhibitors and methods of use thereof The Brigham and Women's Hospital, Inc.; Dept. of Health and Human Services, National Institutes of Health 03/10/182D 3D TSV
US9688615 24 Benzimidazole inhibitors of the sodium channel DEGIACOMO, INTERIM TRUSTEE, MARK G. 03/10/182D 3D TSV
US9688624 272 DP2 antagonist and uses thereof Brickell Biotech, Inc. 03/10/182D 3D TSV
US9687494 4 Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use Ambit Biosciences 03/10/182D 3D TSV
US9687479 600 Multisubstituted aromatic compounds as serine protease inhibitors VERSEON CORPORATION 03/10/182D 3D TSV
US9687478 600 Quinuclidine derivatives and medicinal compositions containing the same ALMIRALL, S.A. 03/10/182D 3D TSV
US9687483 600 Treatment of cerebral cavernous malformations and cerebral aneurysms with Rho kinase inhibitors BIOAXONE BIOSCIENCES, INC. 03/10/182D 3D TSV
US9682991 600 Tricyclic compounds for use as kinase inhibitors FUNDACIÓN CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III 03/10/182D 3D TSV
US9682971 600 1,2,5-Substituted benzimidazoles as flap modulators JANSSEN PHARMACEUTICA NV 02/14/182D 3D TSV
US9682980 600 Positive allosteric modulators of mGluR2 Bristol-Myers Squibb Company 02/14/182D 3D TSV
US9682976 600 Protein kinase C inhibitors and uses thereof Rigel Pharmaceuticals, Inc. 02/14/182D 3D TSV
US9682959 600 Ethynyl derivatives HOFFMANN-LA ROCHE INC. 02/13/182D 3D TSV
US9682965 600 Fumagillol heterocyclic compounds and methods of making and using same Zafgen, Inc. 02/13/182D 3D TSV
US9682966 600 Kappa opioid ligands The Scripps Research Institute 02/13/182D 3D TSV
US9682967 600 N-substituted-5-substituted phthalamic acids as sortilin inhibitors H. Lundbeck A/S 02/13/182D 3D TSV
US9682960 600 Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety ENDORECHERCHE, INC. 02/13/182D 3D TSV
US9682969 600 Phthalazinone compounds and methods for the treatment of cystic fibrosis Flatley Discovery Lab, LLC 02/13/182D 3D TSV
US9682968 600 Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof Novartis AG 02/13/182D 3D TSV
US9682963 600 Pyridine derivatives as soft rock inhibitors Redx Pharma PLC 02/13/182D 3D TSV
US9682961 600 Quinazoline derivative CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER 02/13/182D 3D TSV
US9682953 600 Amide compounds, compositions and applications thereof ADVINUS THERAPEUTICS LIMITED 02/07/182D 3D TSV
US9687476 600 Bisaryl-bonded aryltriazolones and use thereof Bayer Intellectual Property GmbH 02/07/182D 3D TSV
US9682141 600 Combination of kinase inhibitors and uses thereof Intellikine LLC 02/07/182D 3D TSV
US9682957 600 Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity Theravance Respiratory Company, LLC 02/07/182D 3D TSV
US9682940 600 Indazole derivatives useful as CB-1 inverse agonists Janssen Pharmaceutica NV 02/07/182D 3D TSV
US9682955 600 Quinazoline derivatives useful as CB-1 inverse agonists Janssen Pharmaceutica NV 02/07/182D 3D TSV
US9695195 600 5-HT3 receptor antagonists Takeda Pharmaceutical Company Limited 02/06/182D 3D TSV
US9695205 600 Amide compounds for treatment of complement mediated disorders Achillion Pharmaceuticals, Inc. 02/06/182D 3D TSV
US9695197 600 Glycosidase inhibitors and uses thereof Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp. 02/06/182D 3D TSV
US9695200 600 Heterocyclic ITK inhibitors for treating inflammation and cancer Confluence Life Sciences, Inc. 02/06/182D 3D TSV
US9695194 600 Benzoxazinone derivatives for treatment of skin diseases SIXERA PHARMA AB 01/26/182D 3D TSV
US9695172 600 Diazepane derivatives and uses thereof Dana-Farber Cancer Institute, Inc. 01/26/182D 3D TSV
US9695175 600 Highly selective c-Met inhibitors as anticancer agents CB THERAPEUTICS INC. 01/26/182D 3D TSV
US9695181 600 Hydroximic acid derivatives and medical applications therof DOUBLE RIDER MEDICINE CO., LTD. 01/26/182D 3D TSV
US9695174 600 Inhibitor of breast cancer resistance protein (BCRP) Millennium Pharmaceuticals, Inc. 01/26/182D 3D TSV
US9695179 600 Methods and compositions for inhibition of bromodomain-containing proteins ConverGene LLC 01/26/182D 3D TSV
US9695170 600 Naphthyridine derivatives as inhibitors of Hypoxia inducible factor (HIF) hydroxylase FibroGen, Inc. 01/26/182D 3D TSV
US9695183 600 Substituted 7-azabicycles and their use as orexin receptor modulators JANSSEN PHARMACEUTICA NV 01/26/182D 3D TSV
US9695180 600 Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors Incyte Corporation 01/26/182D 3D TSV
US9695176 600 Substituted imidazo[1,5-a]pyrazines as CGRP receptor antagonists Bristol-Myers Squibb Company 01/26/182D 3D TSV
US9695131 4 Substituted uracils as chymase inhibitors Bayer Pharma Aktiengesellschaft 01/19/182D 3D TSV
US9334268 25 4-amino-imidazoquinoline compounds HOFFMAN-LA ROCHE INC. 05/15/172D 3D TSV
US9340534 4 Compounds and methods for treating ocular diseases ALLERGAN, INC. 05/15/172D 3D TSV
US9328106 297 Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use GENENTECH, INC. 05/15/172D 3D TSV
US9339486 15 Heterocyclic modulators of cannabinoid receptors The Cleveland Clinic Foundation 05/15/172D 3D TSV
US9333217 10 Inhibitors of human EZH2, and methods of use thereof Epizyme, Inc. 05/15/172D 3D TSV
US9333205 6 Isoxazolo-quinazolines as modulators of protein kinase activity NERVIANO MEDICAL SCIENCES S.R.L. 05/15/172D 3D TSV
US9333199 13 Methods of treatment of histamine H-4 receptor-related pruritus associated with nerve disorders BRIDGE PHARMA, INC. 05/15/172D 3D TSV
US9340511 7 Process for making isoquinoline compounds FibroGen, Inc. 05/15/172D 3D TSV
US9334271 32 Purine derivatives and their use in the treatment of disease Novarits AG 05/15/172D 3D TSV
US9321790 119 Pyrimidinone derivatives as antimalarial agents Sanofi 05/15/172D 3D TSV
US9334278 38 Pyrrolo[2,3-B]pyrazines as SYK inhibitors Hoffmann-La Roche Inc. 05/15/172D 3D TSV
US9328096 800 Tropomyosin-related kinase inhibitors Pfizer Inc. 05/15/172D 3D TSV
US9328120 34 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders Boehringer Ingelheim International GmbH 05/08/172D 3D TSV
US9321791 46 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions Boehringer Ingelheim International GmbH 05/08/172D 3D TSV
US9326978 16 A3 adenosine receptor allosteric modulators The United States of America, Represented by the Secretary, Dept. of Health and Human Services; Universiteit Leiden 05/08/172D 3D TSV
US9321760 243 Aminopyrimidine derivatives for use as modulators of kinase activity Merck Patent GmbH 05/08/172D 3D TSV
US9333197 9 Apoptosis signal-regulating kinase inhibitor Gilead Sciences, Inc. 05/08/172D 3D TSV
US9321756 823 Azole compounds as PIM inhibitors AMGEN INC. 05/08/172D 3D TSV
US9328124 3 BACE inhibitors Eli Lilly and Company 05/08/172D 3D TSV
US9321773 21 Compounds Respivert, Ltd. 05/08/172D 3D TSV
US9328070 8 Ethynyl derivatives Hoffmann-La Roche Inc. 05/08/172D 3D TSV
US9328118 159 Nitrogen-containing bicyclic aromatic heterocyclic compound Astellas Pharma Inc. 05/08/172D 3D TSV
US9328123 5 Rotenone derivatives and a use thereof Korea Atomic Energy Research Institute 05/08/172D 3D TSV
US9328111 39 Substituted cycloocta[5,6]pyrido[4,3,2-de]phthalazines as PARP inhibitors BeiGene Ltd. 05/08/172D 3D TSV
US9328112 193 Tetracyclic CDK9 kinase inhibitors AbbVie Inc. 05/03/172D 3D TSV
US9315520 135 2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides Pfizer Inc. 05/01/172D 3D TSV
US9321748 59 Aminopyridine derived compounds as LRRK2 inhibitors H. Lundbeck A/S; Vernalis (R&D) Ltd. 05/01/172D 3D TSV
US9321728 33 Beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredient KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY; HANDOK PHARMACEUTICALS CO., LTD. 05/01/172D 3D TSV
US9320741 14 Compositions and methods for treating neoplasia, inflammatory disease and other disorders DANA-FARBER CANCER INSTITUTE, INC. 05/01/172D 3D TSV
US9321743 25 Compositions and methods of inhibiting N-acylethanolamine-hydrolyzing acid amidase The Regents of the University of California; Universita Degli Studi Di Parma; Universita Degli Studi Di Urbino “Carlo Bo” 05/01/172D 3D TSV
US9321766 10 Kinase inhibitors Allergan, Inc. 05/01/172D 3D TSV
US9321738 28 N-alkyltriazole compounds as LPAR antagonists HOFFMAN-LA ROCHE INC. 05/01/172D 3D TSV
US9321752 10 Pyrazole derivative GREEN TECH CO., LTD. 05/01/172D 3D TSV
US9321750 5 ROR modulators and their uses INNOV17 LLC 05/01/172D 3D TSV
US9320722 81 Regulators of aldehyde dehydrogenase ALDH3A1 and related therapeutic methods Indiana University Research and Technology Corporation 05/01/172D 3D TSV
US9320734 110 Small molecule inhibitors of the pleckstrin homology domain and methods for using same Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona 05/01/172D 3D TSV
US20160326143 65 Compounds and uses Astrazeneca Ab 04/27/172D 3D TSV
US9320732 21 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase Incyte Corporation; Incyte Holdings Corporation 04/24/172D 3D TSV
US9315514 32 1,3-dioxanomorphides and 1,3-dioxanocodides Rhodes Technologies 04/24/172D 3D TSV
US9321747 21 Acid addition salt of substituted pyridine compound DAIICHI SANKYO COMPANY, LIMITED; UBE INDUSTRIES, LTD. 04/24/172D 3D TSV
US9315498 174 Arlethynyl derivatives HOFFMAN-LA ROCHE INC. 04/24/172D 3D TSV
US9315500 26 Bicyclic heteroaryl cycloalkyldiamine derivatives NOVARTIS AG 04/24/172D 3D TSV
US9315489 98 Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Novartis AG 04/24/172D 3D TSV
US9315499 41 Cytomegalovirus inhibitor compounds Boehringer Ingelheim International GmbH 04/24/172D 3D TSV
US9315519 6 Guanidine substituted tetrahydroisoquinoline compounds as factor XIa inhibitors Bristol-Myers Squibb Company 04/24/172D 3D TSV
US9315518 40 Imidazopyridin-2-one derivatives Merck Sharp & Dohme Corp. 04/24/172D 3D TSV
US9321721 8 Kinase inhibitors Allergan, Inc. 04/24/172D 3D TSV
US9315493 18 Phenylpyridine derivative and drug containing same KOWA COMPANY, LTD. 04/24/172D 3D TSV
US9315491 129 Pyrimidine compounds as mTOR and PI3K inhibitors DEVELOPMENT CENTER FOR BIOTECHNOLOGY; DCB-USA LLC 04/24/172D 3D TSV
US9320737 32 Substituted imidazopyridazines BAYER INTELLECTUAL PROPERTY GMBH 04/24/172D 3D TSV
US9315508 3 Treating diabetes with dipeptidyl peptidase-IV inhibitors Merck sharp & Dohme Corp. 04/24/172D 3D TSV
US9303017 131 2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof Georgetown University; Duke University 04/10/172D 3D TSV
US9303045 162 5-HT3 receptor antagonists Takeda Pharmaceutical Company Limited 04/10/172D 3D TSV
US9303025 407 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases AbbVie Inc. 04/10/172D 3D TSV
US9314468 140 Chemokine receptor modulators Altiris Therapeutics, Inc. 04/10/172D 3D TSV
US9314464 22 Compounds and compositions as protein kinase inhibitors Novartis AG 04/10/172D 3D TSV
US9315463 30 Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities Almirall, S.A. 04/10/172D 3D TSV
US9303015 151 Heteroaryl linked quinolinyl modulators of RORγt JANSSEN PHARMACEUTICA NV 04/10/172D 3D TSV
US9315492 29 Heterocyclic group contained amino-methanol derivative, and salt, synthetic method and use thereof Beijing Foreland Biopharma Co., Ltd. 04/10/172D 3D TSV
US9315438 10 Optically pure benzyl-4-chlorophenyl-C-glucoside derivative XUANZHU PHARMA CO., LTD 04/10/172D 3D TSV
US9303023 145 Pyrazole and imidazole derivatives useful as orexin antagonists ACTELION PHARMACEUTICALS LTD. 04/10/172D 3D TSV
US9303012 304 Pyridine-2-amides useful as CB2 agonists HOFFMAN-LA ROCHE INC. 04/10/172D 3D TSV
US9303035 36 Substituted pyrazino[1′,2′:1,2]pyrrolo[3,4-d]pyrimidines, pyrimido[4′,5′:3,4]pyrrolo[2,1-c][1,4]oxazines and pyrimido[4′,5′:3,4]pyrrolo[1,2-d][1,4]oxazepines for inhibiting the CFTR channel Novartis AG 04/10/172D 3D TSV
US9284322 30 Nicotinic receptor compounds Research Triangle Institute 04/04/172D 3D TSV
US9296759 188 Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use Amgen Inc. 04/03/172D 3D TSV
US9290488 165 Azetidine-substituted quinoxalines as opioid receptor like-1 modulators Purdue Pharma L.P. 04/03/172D 3D TSV
US9271961 119 Bifunctional AKR1C3 inhibitors/androgen receptor modulators and methods of use thereof The Trustees of the University of Pennsylvania 04/03/172D 3D TSV
US9296741 698 Bromodomain inhibitors AbbVie Inc. 04/03/172D 3D TSV
US9296708 17 Chimeric small molecules for the recruitment of antibodies to cancer cells YALE UNIVERSITY 04/03/172D 3D TSV
US9302996 148 Continuous arycyclic compound MITSUBISHI TANABE PHARMA CORPORATION 04/03/172D 3D TSV
US9278100 149 Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors Pharmacyclics LLC 04/03/172D 3D TSV
US9290476 160 Methylene linked quinolinyl modulators of RORγt JANSSEN PHARMACEUTICA NV 04/03/172D 3D TSV
US9271963 95 Selective inhibitors of human corticosteroid synthases UNIVERSITAT DES SAARLANDES 04/03/172D 3D TSV
US9278925 146 Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one BAYER INTELLECTUAL PROPERTY GMBH 04/03/172D 3D TSV
US9302986 97 Substituted 3-haloallylamine inhibitors of ASSAO and uses thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH 04/03/172D 3D TSV
US9303033 2239 Pyrazolopyrimidines and related heterocycles as CK2 inhibitors SENHWA BIOSCIENCES, INC. 03/30/172D 3D TSV
US9302985 17 Benzyl sulfonamide derivatives as RORc modulators Genentech, Inc. 03/21/172D 3D TSV
US9212182 776 Bicyclic sulfonamide compounds as sodium channel inhibitors Amgen Inc. 03/21/172D 3D TSV
US9296681 36 Cycloalkylmethylamines REVIVA PHARMACEUTICALS, INC. 03/21/172D 3D TSV
US9289400 6 D3 dopamine receptor agonists to treat dyskinesia in parkinson's disease Drexel University; Rutgers, The State University of New Jersey 03/21/172D 3D TSV
US9284333 390 Fused pyrroledicarboxamides and their use as pharmaceuticals Sanofi 03/21/172D 3D TSV
US9249087 156 HDAC inhibitors and therapeutic methods using the same THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS; THE CHILDREN'S HOSPITAL OF PHILADELPHIA 03/21/172D 3D TSV
US9290501 16 Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase Albert Einstein College of Medicine, Inc.; Victoria Link Limited 03/21/172D 3D TSV
US9296757 92 Substituted benzothienopyrimidines BAYER PHARMA AKTIENGESELLSCHAFT 03/21/172D 3D TSV
US9260435 16 Substituted imidazopyrazines as Akt kinase inhibitors BAYER PHARMA AKTIENGESELLSCHAFT 03/21/172D 3D TSV
US9303018 23 Inhibitors of leukotriene production Boehringer Ingelheim International GmbH 03/13/172D 3D TSV
US9302989 1657 NAMPT and rock inhibitors AbbVie Inc. 03/13/172D 3D TSV
US9303019 12 Amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome UNIVERSITE DE STRASBOURG 03/06/172D 3D TSV
US9296745 236 Diacylglycerol acyltransferase 2 inhibitors Pfizer Inc. 03/06/172D 3D TSV
US9296734 722 Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use Amgen Inc. 03/06/172D 3D TSV
US9296736 497 Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Amgen INC. 03/06/172D 3D TSV
US9296748 113 Pyridinones Boehringer Ingelheim International GmbH 03/06/172D 3D TSV
US9302981 6 Synthesis, methods of using, and compositions of cycloalkylmethylamines REVIVA PHARMACEUTICALS, Inc. 03/06/172D 3D TSV
US9303005 4 Use of dibenzofuranone derivatives to inhibit kinases TBA 03/06/172D 3D TSV
US9296747 30 Piperidylpyrimidine derivatives as modulators of protein kinase inhibitors and of vascular endothelial growth factor receptor 2 Allergan, Inc. 02/28/172D 3D TSV
US9296703 2 Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors University of Utah Research Foundation 02/28/172D 3D TSV
US9296728 26 Therapeutic compounds Regents of the University of Minnesota 02/28/172D 3D TSV
US9284330 29 1,4-dihydro-naphthyridine derivative and pharmaceutical composition and use thereof Jiangsu Simovay Pharmaceutical Co., Ltd. 02/27/172D 3D TSV
US9296693 133 Acyl piperidine inhibitors of soluble epoxide hydrolase The Regents of the University of California 02/27/172D 3D TSV
US9284319 34 Heterocyclyl aminoimidazopyridazines BAYER INTELLECTUAL PROPERTY GMBH 02/27/172D 3D TSV
US9283222 773 Inhibitors of poly(ADP-ribose)polymerase AbbVie Inc. 02/27/172D 3D TSV
US9295672 37 Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof Ambit Biosciences Corporation 02/27/172D 3D TSV
US9278978 83 6-Alkynyl Pyridine Boehringer Ingelheim International GmbH 02/21/172D 3D TSV
US9278976 8 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes Merck Sharp & Dohme Corp. 02/21/172D 3D TSV
US9278981 551 Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Novartis AG 02/21/172D 3D TSV
US9284302 4 Cyclobutyl benzimidazoles as PDE 10 inhibitors Merck Sharp & Dohme Corp. 02/21/172D 3D TSV
US9278968 106 Imidazopyridine compounds Astellas Pharma Inc. 02/21/172D 3D TSV
US9284284 64 Oxazine derivatives and their use in the treatment of disease NOVARTIS AG 02/21/172D 3D TSV
US9296775 3 Pyrazole compounds ELI LILLY AND COMPANY 02/21/172D 3D TSV
US9284298 8 Pyrazolyl-pyrimidine derivatives as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 02/21/172D 3D TSV
US9283225 2 Pyrido-pyrimidine derivatives Merck Patent GmbH 02/21/172D 3D TSV
US9284299 58 Substituted 1H-indazol-1-ol analogs as inhibitors of beta catenin/Tcf protein-protein interactions University of Utah Research Foundation 02/21/172D 3D TSV
US9284317 29 Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitors Bayer Intellectual Property GmbH 02/21/172D 3D TSV
US9284315 32 Three-ring PI3K and/or mTOR inhibitor ZUANZHU PHARMA CO., LTD. 02/21/172D 3D TSV
US9290517 25 Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives Merck Sharp & Dohme Corp. 02/14/172D 3D TSV
US9278963 124 Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors Acetylon Pharmaceuticals, Inc. 02/14/172D 3D TSV
US9278960 315 Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use Merck Sharp & Dohme Corp. 02/14/172D 3D TSV
US9278093 8 Aldosterone synthase inhibitors Merck Sharp & Dohme Corp.; ElexoPharm GmbH 02/13/172D 3D TSV
US9278953 14 Antagonists of prostaglandin EP3 receptor Pfizer Inc. 02/13/172D 3D TSV
US9278930 32 Methods for increasing the stabilization of hypoxia inducible factor-α AERPIO THERAPEUTICS, INC. 02/13/172D 3D TSV
US9278944 131 Nitrogen-containing saturated heterocyclic compound MITSUBISHI TANABE PHARMA CORPORATION; SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. 02/13/172D 3D TSV
US8772490 5 Optically active diazabicyclooctane derivatives and process for preparing the same Meiji Seika Pharma Co., Ltd. 02/13/172D 3D TSV
US9278954 172 Pyrrolidine derivatives, pharmaceutical compositions and uses thereof Boehringer Ingelheim International GmbH 02/13/172D 3D TSV
US9278914 5 SARMs and method of use thereof University of Tennessee Research Foundation 02/13/172D 3D TSV
US9278918 32 Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors Hoffmann-La Roche Inc. 02/13/172D 3D TSV
US9290482 8 Amino-substituted imidazopyridazines BAYER PHARMA AKTIENGESELLSCHAFT 02/06/172D 3D TSV
US9290490 33 Aminopyrimidines as Syk inhibitors Merck Sharp & Dohme Corp. 02/06/172D 3D TSV
US9290507 137 B-RAF kinase inhibitors Boehringer Ingelheim International GmbH 02/06/172D 3D TSV
US9290481 13 Monocyclic heteroaryl cycloalkyldiamine derivatives NOVARTIS AG 02/06/172D 3D TSV
US9290485 183 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides NOVARTIS AG 02/06/172D 3D TSV
US9290487 74 Pharmaceutical composition for treating diabetes AJINOMOTO CO., INC. 02/06/172D 3D TSV
US9290459 353 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity Boehringer Ingelheim International GmbH 02/06/172D 3D TSV
US9290457 215 Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity Boehringer Ingelheim International GmbH 02/06/172D 3D TSV
US9290505 22 Substituted imidazo[1,2-a]pyrazines as Syk inhibitors Gilead Sciences, Inc. 02/06/172D 3D TSV
US9247759 464 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof Senomyx, Inc. 02/02/172D 3D TSV
US9290467 51 Cyclic amides HOFFMANN—LA ROCHE INC. 01/30/172D 3D TSV
US9273046 116 Fused tricyclic compounds as Raf kinase inhibitors BeiGene, LTD. 01/30/172D 3D TSV
US9290477 7 Inhibitors of β-secretase Vitae Pharmaceuticals, Inc. 01/30/172D 3D TSV
US9290456 68 Pyridazinone compounds and their use as DAAO inhibitors Takeda Pharmaceutical Company Limited 01/30/172D 3D TSV
US9290451 758 Pyridine derivatives as agonists of the CB2 receptor Hoffmann-La Roche Inc. 01/30/172D 3D TSV
US9290463 5 Radiolabeled compounds and uses thereof The Trustees of Columbia University in the City of New York 01/30/172D 3D TSV
US9290454 27 Substituted isoquinolines as CRTH2 receptor modulators Merck Sharp & Dohme Corp. 01/30/172D 3D TSV
US9273053 82 Sulfur-containing heterocyclic derivative having Beta secretase inhibitory activity Shionogi & Co., Ltd. 01/30/172D 3D TSV
US9273043 82 TRPV1 antagonists including dihydroxy substituent and uses thereof Purdue Pharma L.P.; Shionogi & Co., Ltd. 01/30/172D 3D TSV
US9249124 141 Aurora kinase inhibitors and methods of making and using thereof H. Lee Moffitt Cancer Center and Research Institute, Inc. 01/27/172D 3D TSV
US9273042 9 5-amino[1,4]thiazines as BACE 1 inhibitors HOFFMANN-LA ROCHE INC. 01/25/172D 3D TSV
US9273014 82 Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof Bristol-Myers Squibb Company 01/24/172D 3D TSV
US9266877 359 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases ABBVIE INC. 01/23/172D 3D TSV
US9271969 134 Compounds as inhibitors of diacylglycerol O-acyltransferase type 1 enzyme KAINOS MEDICINE, INC. 01/23/172D 3D TSV
US9273021 6 Dibenzofuran derivatives as inhibitors of fructose 1,6-bisphosphatase and methods of use thereof TRUSTEES OF BOSTON COLLEGE 01/23/172D 3D TSV
US9273052 5 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof Jiangsu Hansoh Pharmaceutical Co., Ltd. 01/23/172D 3D TSV
US9273029 119 Pyridine-and pyrazine derivatives Merck Patent GmbH 01/23/172D 3D TSV
US9266890 24 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders Dana-Farber Cancer Institute, Inc. 01/23/172D 3D TSV
US9271981 7 Pyrrolo[2,3-D]pyrimidine compounds Zoetis Services LLC 01/23/172D 3D TSV
US9266883 144 Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors Novartis AG 01/23/172D 3D TSV
US9266891 61 Substituted [1,2,4]triazolo[4,3-A]pyrazines that are BRD4 inhibitors Boehringer Ingelheim International GmbH 01/23/172D 3D TSV
US9273011 14 Substituted pyridazines for the treatment of pain Inhibitaxin Limited 01/23/172D 3D TSV
US9273033 142 Substituted pyridone derivatives as PDE10 inhibitors Merck Sharp & Dohme Corp. 01/23/172D 3D TSV
US9243038 35 Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereof President and Fellows of Harvard College 01/18/172D 3D TSV
US9233167 124 Oligomer-opioid agonist conjugates Nektar Therapeutics 01/18/172D 3D TSV
US9233947 11 Sulfamides as TRPM8 modulators Janssen Pharmaceutica, NV 01/18/172D 3D TSV
US9266876 244 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives Actelion Pharmaceuticals Ltd. 01/17/172D 3D TSV
US9266870 96 Heteroaromatic methyl cyclic amine derivative TAISHO PHARMACEUTICAL CO., LTD 01/17/172D 3D TSV
US9266878 656 Phosphatidylinositol 3-kinase inhibitors Gilead Calistoga LLC 01/17/172D 3D TSV
US9266880 8 Substituted azaindazole compounds Bristol-Myers Squibb Company 01/17/172D 3D TSV
US9266869 118 Substituted dialkyl(oxido)-lambda4-sulfanylidene nicotinamide derivatives as kinase inhibitors Allergan, Inc. 01/17/172D 3D TSV
US9266895 33 Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors Principia Biopharma Inc. 01/17/172D 3D TSV
US9266881 22 Triazolopyridinone PDE10 inhibitors Merck Sharp & Dohme Corp. 01/17/172D 3D TSV
US9266835 362 Quinoline derivatives useful as CB-1 inverse agonists Janssen Pharmaceutica NV 01/16/172D 3D TSV
US9265773 422 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases Merck Sharp & Dohme Corp.; MSD Italia S.R.L. 01/16/172D 3D TSV
US9233921 34 Potent poxvirus inhibitor THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 01/14/172D 3D TSV
US9266848 37 4-alkoxy-N-(2-hydroxycarbamoyl-2-piperidinyl-ethyl)-benzamide compounds as selective TACE-inhibitors for the treatment of inflammatory diseases GALDERMA RESEARCH & DEVELOPMENT 01/09/172D 3D TSV
US9260455 15 Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Pfizer Inc. 01/09/172D 3D TSV
US9265734 416 Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors BIOMARIN PHARMACEUTICAL INC. 01/09/172D 3D TSV
US9266832 90 Compounds for the treatment of neurodegenerative diseases Katholieke Universiteit Levun; K. U. Leuven R&D reMYND 01/09/172D 3D TSV
US9260439 575 Dihydropyrrolopyrimidine derivatives PFIZER INC. 01/09/172D 3D TSV
US9260440 123 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors BeiGene, Ltd. 01/09/172D 3D TSV
US9266828 5 Inhibitors of Furin and other pro-protein convertases SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE 01/09/172D 3D TSV
US9266853 8 Orally available viridiofungin derivative possessing anti-HCV activity Chugai Seiyaku Kabushiki Kaisha 01/09/172D 3D TSV
US9260450 18 Therapeutic pyrazolyl thienopyridines THESAN PHARMACEUTICALS, INC. 01/09/172D 3D TSV
US9266839 2 Trifluoromethyl pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof Lycera Corporation 01/09/172D 3D TSV
US9233965 111 3,4-dihydropyrrolo[1,2-A]pyrazine-2,8(1H)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof for diseases involving casein kinase 1 epsilon and/or casein kinase 1 delta SANOFI 01/07/172D 3D TSV
US9249163 241 PDE10a inhibitors for the treatment of type II diabetes JANSSEN PHARMACEUTICA NV. 12/31/162D 3D TSV
US9492405 97 Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas The United States of America, as represented by the Secretary, Department of Health and Human Services; SRI International 12/31/162D 3D TSV
US9260415 17 Heteroaryl pyridone and aza-pyridone compounds with electrophilic functionality Genentech, Inc. 12/28/162D 3D TSV
US9260413 5 Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders Merck Sharp & Dohme Corp. 12/28/162D 3D TSV
US9259422 35 Orvinol and thevinol derivatives useful in the treatment of depression The University of Bath 12/28/162D 3D TSV
US9260410 8 P38 MAP kinase inhibitors Respivert Ltd. 12/28/162D 3D TSV
US9260425 412 Pyrazolo[3,4-c]pyridine compounds and methods of use Genetech, Inc. 12/28/162D 3D TSV
US9259470 42 Serine/threonine kinase inhibitors Array BioPharma Inc.; Genentech, Inc. 12/28/162D 3D TSV
US9260446 5 Synthetic methods for spiro-oxindole compounds Xenon Pharmaceuticals Inc. 12/28/162D 3D TSV
US9260448 11 Thienopyrimidinone derivatives as mGluR1 antagonists KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 12/28/162D 3D TSV
US9253997 33 Alkylamine derivative AJINOMOTO CO., INC. 12/20/162D 3D TSV
US9255091 15 Benzothiazole-based pyridinium compounds The University of Montana 12/20/162D 3D TSV
US9255107 8 Heteroaryl alkyne compound and use thereof NANJING SANHOME PHARMACEUTICAL CO., LTD. 12/20/162D 3D TSV
US9255090 449 Heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators ACTELION PHARMACEUTICALS LTD. 12/20/162D 3D TSV
US9255110 229 Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators ROCHE PALO ALTO LLC; HOFFMANN-LA ROCHE INC. 12/20/162D 3D TSV
US9255096 26 Substituted 1,2,3,4-tetrahydrobenzo[C][2,7] naphthyridines and derivatives thereof as kinase inhibitors Allergan, Inc. 12/20/162D 3D TSV
US9255106 46 Substituted [1,2,4]triazolo[4,3-a]pyrazines as PARP-1 inhibitors Shanghai Institute of Materia Medica, Chinese Academy of Sciences 12/20/162D 3D TSV
US9255103 59 Substituted pyrazolo[1,5-a]pyrazines as mGluR5 receptor modulators Vanderbilt University 12/20/162D 3D TSV
US9255098 6 Xanthine derivative Chengdu Easton Pharmaceutical Co., Ltd. 12/20/162D 3D TSV
US9260417 14 Therapeutic methods and compositions involving allosteric kinase inhibition AMITECH THERAPEUTIC SOLUTIONS, INC. 12/15/162D 3D TSV
US9249085 61 Aniline derivatives, their preparation and their therapeutic application FOVEA PHARMACEUTICALS 12/12/162D 3D TSV
US9249151 126 Bis-amido pyridines Boehringer Ingelheim International GmbH 12/12/162D 3D TSV
US9248140 66 Chemical compounds AstraZeneca AB 12/12/162D 3D TSV
US9249139 9 Indolizinone based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof Council of Scientific & Industrial Research 12/12/162D 3D TSV
US9249125 371 Pyrazole derivatives as p38 MAP inhibitors RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED 12/12/162D 3D TSV
US9249123 8 Pyridinones/pyrazinones, method of making, and method of use thereof Genentech, Inc.; Gilead Connecticut, Inc. 12/12/162D 3D TSV
US9249096 30 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors Bristol-Myers Squibb Company 12/12/162D 3D TSV
US9243020 20 Selective glycosidase inhibitors and uses thereof Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp. 12/12/162D 3D TSV
US9255087 12 Substituted indazole derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 12/12/162D 3D TSV
US9249114 74 Thiazole derivatives Merck Patent GmbH 12/12/162D 3D TSV
US9227979 64 Fluorescent antagonists of the A3 adenosine receptor The United States of America, as represented by The Secretary, Department of Health and Human Services; Universita Degli Studi Di Trieste; Universita Degli Studi Di Padova 12/08/162D 3D TSV
US9260454 41 Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals SANOFI 12/08/162D 3D TSV
US9242977 42 Trk-inhibiting compound ONO PHARMACEUTICAL CO., LTD. 12/06/162D 3D TSV
US9242988 7 2′-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases Merck Sharp & Dohme Corp. 12/05/162D 3D TSV
US9242996 573 Aminoheteroaryl benzamides as kinase inhibitors Novartis AG 12/05/162D 3D TSV
US9242973 532 Chromane compounds COMENTIS, INC. 12/05/162D 3D TSV
US9242998 118 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C Merck Sharp & Dohme Corp. 12/05/162D 3D TSV
US9243002 192 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C Merck Sharp & Dohme Corp. 12/05/162D 3D TSV
US9221809 356 Aminopyrimidinones as interleukin receptor-associated kinase inhibitors MERCK SHARP & DOHME CORP. 11/29/162D 3D TSV
US9242943 66 1,4 oxazines as BACE1 and/or BACE2 inhibitors SIENA BIOTECH S.P.A.; HOFFMANN-LA ROCHE INC. 11/28/162D 3D TSV
US9242969 416 Biaryl amide compounds as kinase inhibitors Novartis AG 11/28/162D 3D TSV
US9238625 33 Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives REVIVA PHARMACEUTICALS, INC. 11/28/162D 3D TSV
US9242981 44 Fused pyrazole derivatives as novel ERK inhibitors Merck Sharp & Dohme Corp. 11/28/162D 3D TSV
US9242975 27 Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors Bristol-Myers Squibb Company 11/28/162D 3D TSV
US9242995 3 Isoxazolopyridine orexin receptor antagonists MERCK SHARP & DOHME CORP. 11/28/162D 3D TSV
US9242970 930 Lactam derivatives useful as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD. 11/28/162D 3D TSV
US9242960 4 P38MAP kinase inhibitors Respivert, Ltd. 11/28/162D 3D TSV
US9242982 7 Pyridopyrimidine based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH 11/28/162D 3D TSV
US9242957 72 Thiophene-2-carboximidamide based selective neuronal nitric oxide inhibitors Northwestern University 11/28/162D 3D TSV
US9238651 72 1-H-pyrrolo[2,3-b]pyridine derivatives MERCK PATENT GMBH 11/21/162D 3D TSV
US9238626 42 Beta-amyloid-directed multitarget compounds for the treatment of alzheimer's disease UNIVERSITAT DE BARCELONA; PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE 11/21/162D 3D TSV
US9233979 458 Compounds that are ERK inhibitors Merck Sharp & Dohme Corp. 11/21/162D 3D TSV
US9238629 88 Heteroaryl compounds and uses thereof Celgene Avilomics Research, Inc. 11/21/162D 3D TSV
US9241942 494 IRE-1α inhibitors MannKind Corporation 11/21/162D 3D TSV
US9238619 76 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG; AbbVie Inc. 11/21/162D 3D TSV
US9233983 152 Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof ADVINUS THERAPEUTICS LIMITED 11/21/162D 3D TSV
US9233981 33 Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Pfizer Inc. 11/21/162D 3D TSV
US9238658 49 Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitors Janssen Pharmaceutica NV 11/21/162D 3D TSV
US9238644 143 VEGFR3 inhibitors CANCER THERAPEUTICS CRC PTY LIMITED 11/21/162D 3D TSV
US9187424 434 Aryl dihydropyridinones and piperidinone MGAT2 inhibitors Bristol-Myers Squibb Company 11/15/162D 3D TSV
US9227969 101 Compounds and compositions as inhibitors of MEK NOVARTIS AG 11/14/162D 3D TSV
US9233108 30 Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities ALMIRALL, S.A. 11/14/162D 3D TSV
US9233953 161 Derivatives of 4-(piperazinylcarbonyl)thiane-1, 1-dione which inhibit GlyT1 Boehringer Ingelheim International GmbH 11/14/162D 3D TSV
US9226927 15 Gamma secretase inhibitors MERCK SHARP & DOHME CORP. 11/14/162D 3D TSV
US9233086 100 Inhibition of WDR5 interaction with its binding partners THE REGENTS OF THE UNIVERSITY OF MICHIGAN 11/14/162D 3D TSV
US9233968 97 Kinase inhibitors Allergan, Inc. 11/14/162D 3D TSV
US9227975 60 Method of treatment using substituted imidazo[1,2B]pyridazine compounds Array BioPharma, Inc. 11/14/162D 3D TSV
US9227977 14 Phosphoinositide 3-kinase inhibitors Respivert Ltd. 11/14/162D 3D TSV
US9227973 16 Pyridine CGRP receptor antagonists Merck Sharp & Dohme Corp. 11/14/162D 3D TSV
US9233111 72 Pyrrolo pyrimidine derivatives NOVARTIS AG 11/14/162D 3D TSV
US9227956 98 Substituted amide compounds Pfizer Inc. 11/14/162D 3D TSV
US9233946 59 Sulfonamide compounds KANCERA AB 11/14/162D 3D TSV
US9227970 43 Triazolopyridine compounds Hoffmann-La Roche, Inc. 11/14/162D 3D TSV
US9227982 56 4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrminidinyl compounds for use as tankyrase inhibitors NOVARTIS AG 11/08/162D 3D TSV
US9227930 16 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG 11/08/162D 3D TSV
US9234000 417 Benzylamine derivatives as inhibitors of plasma kallikrein Kalvista Pharmaceuticals Limited 11/08/162D 3D TSV
US9221831 451 Buprenorphine analogs Purdue Pharma, L.P. 11/08/162D 3D TSV
US9226922 476 Compounds that are ERK inhibitors Merck Sharp & Dohme Corp. 11/08/162D 3D TSV
US9227959 8 Ethynyl derivatives Hoffman-La Roche Inc. 11/08/162D 3D TSV
US9227949 188 Heteroarylcarboxylic acid ester derivative AJINOMOTO CO., INC. 11/08/162D 3D TSV
US9221808 178 Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinase (ROCK) and methods of use H. Lee Moffitt Cancer Center and Research Institute, Inc. 11/08/162D 3D TSV
US9226923 19 Spirocyclic molecules as protein kinase inhibitors Nanjing Allgen Pharma Co. Ltd. 11/08/162D 3D TSV
US9216998 56 Tricyclic indole derivatives useful endothelial lipase inhibitors Janssen Pharmaceutica NV 11/08/162D 3D TSV
US9217012 22 Inhibitors of protein tyrosine phosphatases Indiana University Research and Technology Corporation 11/02/162D 3D TSV
US9221802 10 Arylethynyl derivatives Hoffman-La Roche Inc. 10/31/162D 3D TSV
US9221839 30 C5-C6 oxacyclic-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 10/31/162D 3D TSV
US9221832 152 Heterocyclic amide derivatives as P2X7 receptor antagonists ACTELION PHARMACEUTICALS LTD. 10/31/162D 3D TSV
US9221824 5 Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors Incyte Holdings Corporation; Incyte Corporation 10/31/162D 3D TSV
US9221797 93 Inhibitors of c-fms kinase Janssen Pharmaceutica NV 10/31/162D 3D TSV
US9221791 18 Metalloenzyme inhibitor compounds Viamet Pharmaceuticals, Inc. 10/31/162D 3D TSV
US9221828 21 N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]sulfonamides as pharmaceuticals SANOFI 10/31/162D 3D TSV
US9221796 174 Selective NR2B antagonists Bristol-Myers Squibb Company 10/31/162D 3D TSV
US9216999 1840 Substituted pyrrolo[2,3-h][1,6]naphthyridines and compositions thereof as JAK inhibitors Nissan Chemical Industries, Ltd. 10/31/162D 3D TSV
US9216984 12 3-[4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane—or heptane-nitrile as JAK inhibitors Incyte Corporation; Incyte Holdings Corporation 10/24/162D 3D TSV
US9216985 41 3-aryl-2-((arylamino)methyl)quinazolin-4-(3H)-ones SciFluor Life Sciences, Inc. 10/24/162D 3D TSV
US9221790 16 Benzamide derivatives Dong-A Pharm. Co., Ltd. 10/24/162D 3D TSV
US9216988 210 Benzyl sulfonamide derivatives as RORc modulators Genentech, Inc. 10/24/162D 3D TSV
US9216968 239 Heterocyclic derivative and pharmaceutical drug NIPPON SHINYAKU CO., LTD. 10/24/162D 3D TSV
US9221795 143 Phosphatidylinositol 3-kinase inhibitors Gilead Sciences, Inc. 10/24/162D 3D TSV
US9216981 88 Purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against Raf kinase, containing same as active ingredient Medpacto, Inc. 10/24/162D 3D TSV
US9216986 52 Quinoline derivatives as PDE10A enzyme inhibitors H. Lundbeck A/S 10/24/162D 3D TSV
US9221767 26 Substituted phthalazinones as rock inhibitors Bristol-Myers Squibb Company 10/24/162D 3D TSV
US9216962 216 Thiazole compounds, methods for preparation and use thereof Shanghai Puyi Chemical Co., Ltd. 10/24/162D 3D TSV
US9216997 21 Tri-heterocyclic derivatives, preparation process and uses thereof Shanghai De Novo Pharmatech Co Ltd. 10/24/162D 3D TSV
US9216972 69 Tricyclic heterocyclic compounds Bristol-Myers Squibb Company 10/24/162D 3D TSV
US9090621 104 Tyrosine kinase inhibitors Principia Biopharma Inc. 10/19/162D 3D TSV
US9212206 8 4-Fluoro-Thio-containing inhibitors of APP2, compositions thereof and method of use TBA 10/18/162D 3D TSV
US9216182 192 Carbamate/urea derivatives containing piperidin and piperazin rings as H3 receptor inhibitors Novartis AG 10/18/162D 3D TSV
US9206164 111 Pyrazole compounds as CRTH2 antagonists Boehringer Ingelheim International GmbH 10/18/162D 3D TSV
US9212144 43 2-aminoquinoline-based compounds for potent and selective neuronal nitric oxide synthase inhibition Northwestern University 10/17/162D 3D TSV
US9212184 4 6-thio-substituted imidazo[1,2-a]pyrazines as Mps-1 inhibitors BAYER INTELLECTUAL PROPERTY GMBH 10/17/162D 3D TSV
US9212192 59 Bicyclic carboxamide inhibitors of kinases AbbVie Inc. 10/17/162D 3D TSV
US9212186 25 Bicyclic pyrazole LRRK2 small molecule inhibitors Genentech, Inc. 10/17/162D 3D TSV
US9212147 64 Dihydroxy aromatic heterocyclic compound Takeda Pharmaceutical Company Limited 10/17/162D 3D TSV
US9212171 46 Ethynyl compounds HOFFMANN-LA ROCHE INC. 10/17/162D 3D TSV
US9212196 105 Hypophosphorous acid derivatives having antihyperalgic activity and biological applications thereof UNIVERSITE PARIS DESCARTES; UNIVERSITE D'AUVERGNE 10/17/162D 3D TSV
US9212187 13 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation OTSUKA PHARMACEUTICAL CO., LTD. 10/17/162D 3D TSV
US9212173 37 Pyrazole aminopyrimidine derivatives as LRRK2 modulators Genentech, Inc. 10/17/162D 3D TSV
US9212178 35 Substituted pyrimidine compounds and their use as SYK inhibitors Genosco; Oscotec, Inc. 10/17/162D 3D TSV
US9212145 3 Urea derivatives and uses thereof Kala Pharmaceuticals, Inc. 10/17/162D 3D TSV
US9212140 12 (5s,8s)-3-(4′-chlor-3′-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5] dec-3-en-2-one (compound A) for treatment Bayer Intellectual Property GmbH 10/11/162D 3D TSV
US9212139 88 Aryl substituted indoles and their use as blockers of sodium channels Purdue Pharma, L.P. 10/11/162D 3D TSV
US9212165 28 Bicarbocyclic and tricarbocyclic ethynyl derivatives and uses of same H. Lundbeck A/S 10/11/162D 3D TSV
US9206201 4 Boronic acid bearing liphagane compounds as inhibitors of P13K-α and/or β Counsel of Scientific & Industrial Research 10/11/162D 3D TSV
US9212130 181 Heterocyclic derivative and pharmaceutical composition comprising the same SHIONOGI & CO., LTD. 10/11/162D 3D TSV
US9206199 217 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 10/11/162D 3D TSV
US9206232 203 Organic compounds and their uses Novartis AG 10/11/162D 3D TSV
US9206188 228 Substituted pyrrolo[2,3-b]pyridines as ITK and JAK inhibitors ARRIEN PHARMACEUTICALS LLC 10/11/162D 3D TSV
US9211296 35 Therapeutic compounds for blocking DNA synthesis of POX viruses The Trustees of the University of Pennsylvania 10/11/162D 3D TSV
US9206173 137 Heterocyclic compounds for the treatment of stress-related conditions OTSUKA PHARMACEUTICAL CO., LTD. 10/10/162D 3D TSV
US9216974 16 Phenoxazine derivatives and methods of use thereof WASHINGTON UNIVERSITY 10/04/162D 3D TSV
US9206129 53 Agent for treatment of eye diseases Daito Chemix Corporation; Kyoto University 10/03/162D 3D TSV
US9206139 65 Aggrecanase inhibitors Eli Lilly and Company 10/03/162D 3D TSV
US9206184 219 Disubstituted benzothienyl-pyrrolotriazines and uses thereof BAYER INTELLECTUAL PROPERTY GmbH 10/03/162D 3D TSV
US9212153 549 Inhibitors of beta-secretase Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH 10/03/162D 3D TSV
US9206198 113 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 10/03/162D 3D TSV
US9206167 122 Piperazine-substituted benzothiophenes for treatment of mental disorders OTSUKA PHARMACEUTICAL CO., LTD. 10/03/162D 3D TSV
US9206162 53 Triazole compounds that modulate Hsp90 activity Synta Pharmaceuticals Corp. 10/03/162D 3D TSV
US9205085 73 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction Emory University 10/03/162D 3D TSV
US9200020 75 6-oxopurine phosphoribosyltransferase inhibitors THE UNIVERSITY OF QUEENSLAND; INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ASCR, V.V.I. 09/27/162D 3D TSV
US9199981 176 Compounds and compositions as C-kit kinase inhibitors NOVARTIS AG 09/27/162D 3D TSV
US9200268 5 Compounds and methods for purification of serine proteases Portola Pharmaceuticals, Inc. 09/27/162D 3D TSV
US9199976 17 Haematopoietic-prostaglandin D2 synthase inhibitors The University of Queensland 09/27/162D 3D TSV
US9205078 4 N-methyl-2-[3-((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6-ylsulfanyl]-benzamide for the treatment of chronic myelogenous leukemia PFIZER INC. 09/27/162D 3D TSV
US9200006 26 Protease inhibitors MEDIVIR AB 09/27/162D 3D TSV
US9199997 3 Purinone derivative hydrochloride ONO PHARMACEUTICAL CO., LTD. 09/27/162D 3D TSV
US9200016 173 Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) Allergan, Inc.; Exonhit Therapeutics, SA 09/27/162D 3D TSV
US9199999 76 Substituted imidazopyrazines Bayer Intellectual Property GmbH 09/27/162D 3D TSV
US9200001 119 Triazolyl PDE10 inhibitors Merck Sharp & Dohme Corp. 09/27/162D 3D TSV
US9199947 140 Biaryl-propionic acid derivatives and their use as pharmaceuticals Sanofi 09/20/162D 3D TSV
US9199927 112 Guanidinobenzoic acid compound Astellas Pharma Inc. 09/20/162D 3D TSV
US9199944 157 N2,N4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or pharmaceutically acceptable salt thereof, and composition containing same as active ingredient for preventing or treating cancer KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY 09/20/162D 3D TSV
US9199949 11 Selective glycosidase inhibitors and uses thereof Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp. 09/20/162D 3D TSV
US9193689 18 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) 09/19/162D 3D TSV
US9187487 46 Azaindole derivatives as tyrosine kinase inhibitors PRINCIPIA BIOPHARMA, INC. 09/19/162D 3D TSV
US9192603 67 Heterocyclic sulfone mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction Vanderbilt University 09/19/162D 3D TSV
US9193697 39 Oxazole derivatives useful as modulators of FAAH MERCK SHARP & DOHME CORP. 09/19/162D 3D TSV
US9193736 311 PDE 10a inhibitors for the treatment of type II diabetes Janssen Pharmaceutica, NV 09/19/162D 3D TSV
US9193762 57 Selective inhibitors of prolylcarboxypeptidase UNIVERSITY OF MISSISSIPPI 09/19/162D 3D TSV
US9193726 73 Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders Pfizer Inc. 09/19/162D 3D TSV
US9187470 12 Anti-mucus drugs and uses therefor Washington University 09/12/162D 3D TSV
US9187477 16 Azabenzimidazole derivatives Boehringer Ingelheim International GmbH 09/12/162D 3D TSV
US9187486 205 Bicyclic pyridazine compounds as Pim inhibitors AMGEN INC. 09/12/162D 3D TSV
US9187466 60 Bisaryl-bonded aryltriazolones and use thereof Bayer Intellectual Property GmbH 09/12/162D 3D TSV
US9187469 20 Morpholinylbenzotriazines for use in cancer therapy Merck Patent GmbH 09/12/162D 3D TSV
US9187480 48 Peripherally restricted diphenyl purine derivatives Research Triangle Institute 09/12/162D 3D TSV
US9187459 10 Quinazoline-7-ether compounds and methods of use NewGen Therapeutics, Inc. 09/12/162D 3D TSV
US9187474 8 Raf inhibitor compounds Deciphera Pharmaceuticals, LLC; Eli Lilly and Company 09/12/162D 3D TSV
US9187437 45 Substituted oxadiazole compounds BRISTOL-MYERS SQUIBB COMPANY 09/12/162D 3D TSV
US9187450 56 Substituted pyridine compound Daiichi Sankyo Company, Limited 09/12/162D 3D TSV
US9187462 122 Substituted quinazolines as serine/threonine kinase inhibitors Array BioPharma Inc.; Genentech, Inc. 09/12/162D 3D TSV
US9187441 88 p53-Mdm2 antagonists University of Pittsburgh—Of the Commonwealth System of Higher Education 09/12/162D 3D TSV
US9187406 25 Curcumin analogues as zinc chelators and their uses The Research Foundation of State University of New York; Chem-Master International, Inc. 09/06/162D 3D TSV
US9182402 47 Hepsin inhibitors Fred Hutchinson Cancer Research Center 09/06/162D 3D TSV
US9181263 149 Inhibitors of bruton's tyrosine kinase PHARMACYCLICS LLC 09/06/162D 3D TSV
US9187413 6 Peripherally restricted FAAH inhibitors The Regents of the University of California; Universita Degli Studi Di Parma; Universita Degli Studi Di Urbino 09/06/162D 3D TSV
US9187429 211 Phenyl-tetrahydroisoquinoline derivatives HOFFMANN-LA ROCHE INC. 09/06/162D 3D TSV
US9187430 9 Poly (ADP-ribose) polymerase inhibitor CHENGDU DI'AO PHARMACEUTICAL GROUP CO., LTD. 09/06/162D 3D TSV
US9186318 31 Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof Beijing Konruns Pharmaceutical Co., Ltd 09/06/162D 3D TSV
US9187428 150 Substituted dicyanopyridines and use thereof Bayer Intellectual Property GmbH 09/06/162D 3D TSV
US9187397 23 Therapeutic curcumin derivatives STC.UNM 09/06/162D 3D TSV
US9186360 490 Treatment of respiratory disorders using TRPA1 antagonists GLENMARK PHARMACEUTICALS S.A. 09/06/162D 3D TSV
US9181266 321 2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors NOVARTIS AG 08/29/162D 3D TSV
US9181236 290 2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use Merck Sharp & Dohme Corp. 08/29/162D 3D TSV
US9181253 52 Adenosine receptor agonists, partial agonists, and antagonists The United States of America, as represented by the Secretary, Department of Health and Human Services 08/29/162D 3D TSV
US9181272 300 Aldosterone synthase inhibitors Boehringer Ingelheim International GmbH 08/29/162D 3D TSV
US9181279 16 Cyclic amine derivatives as EP4 receptor antagonists ROTTAPHARM BIOTECH S.R.L. 08/29/162D 3D TSV
US9181233 28 Inhibitors of glutaminyl cyclase PROBIODRUG AG 08/29/162D 3D TSV
US9181275 4 Mercaptoamidine derivatives and methods of use AbbVie Inc. 08/29/162D 3D TSV
US9181258 130 Substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-ones as protein kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 08/29/162D 3D TSV
US9181249 142 Substituted pyrido[3,4-b]pyrazines as GPR6 modulators Takeda Pharmaceutical Company Limited 08/29/162D 3D TSV
US9181261 10 TrkA kinase inhibitors, compositions and methods thereof Merck Sharp & Dohme Corp. 08/29/162D 3D TSV
US9181181 77 2-substituted-3-phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease Albireo AB 08/15/162D 3D TSV
US9180122 35 5- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain Takeda Pharmaceutical Company Limited 08/15/162D 3D TSV
US9181219 48 Compounds of modulating TRPV3 function HYDRA BIOSCIENCES, INC. 08/15/162D 3D TSV
US9180116 72 Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions Cayman Chemical Company, Inc. 08/15/162D 3D TSV
US9175357 23 Fragment ligated inhibitors selective for the polo box domain of PLK1 UNIVERSITY OF SOUTH CAROLINA 08/15/162D 3D TSV
US9181185 25 Heteroaryl compounds as sodium channel blockers Purdue Pharma L.P. 08/15/162D 3D TSV
US9181184 18 Method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives Amicus Therapeutics, Inc. 08/15/162D 3D TSV
US9181230 110 Morpholine compounds and uses thereof Hoffmann-La Roche Inc. 08/15/162D 3D TSV
US9180183 18 Phospholipid drug analogs Telormedix SA 08/15/162D 3D TSV
US9181182 40 S1P receptors modulators Akaal Pharma PTY LTD 08/15/162D 3D TSV
US9180120 38 Substituted N-phenethyltriazoloneacetamides and use thereof Bayer Intellectual Property GmbH 08/15/162D 3D TSV
US9181187 12 Therapeutic agent for urinary excretion disorder ONO PHARMACEUTICAL CO., LTD. 08/15/162D 3D TSV
US9180192 46 mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction Vanderbilt University 08/15/162D 3D TSV
US9174997 29 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof Bayer Intellectual Property GmbH 08/08/162D 3D TSV
US9174982 360 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases ABBVIE INC.; GENENTECH, INC.; THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH 08/08/162D 3D TSV
US9175000 27 Buprenorphine analogs Purdue Pharma L.P. 08/08/162D 3D TSV
US9174969 73 Indoline scaffold SHP-2 inhibitors and cancer treatment method UNIVERSITY OF SOUTH FLORIDA 08/08/162D 3D TSV
US9175331 256 Inhibitors of human EZH2, and methods of use thereof Epizyme, Inc. 08/08/162D 3D TSV
US9174974 85 Macrocyclic factor VIIa inhibitors Bristol-Myers Squibb Company 08/08/162D 3D TSV
US9174999 20 Methods and compositions for studying, imaging, and treating pain The Board of Trustees of the Leland Stanford Junior University 08/08/162D 3D TSV
US9174993 27 N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals SANOFI 08/08/162D 3D TSV
US9175320 1 Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof Arena Pharmaceuticals, Inc. 08/08/162D 3D TSV
US9175003 234 Substituted azoanthracene derivatives and intermediates for preparation thereof vTv Therapeutics LLC 08/08/162D 3D TSV
US9173884 107 Inhibitors of phosphodiesterase 11 (PDE11) Trustees of Boston College 08/02/162D 3D TSV
US9173935 18 Phospholipid drug analogs Telormedix SA 08/02/162D 3D TSV
US9174965 6 Pyrimidinylpiperidinyloxypyridone analogues as GPR119 modulators Bristol-Myers Squibb Company 08/02/162D 3D TSV
US9174940 29 TSH receptor antagonizing tetrahydroquinoline compounds Merck Sharp & Dohme B.V. 08/02/162D 3D TSV
US9169270 120 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators Actelion Pharmaceuticals Ltd. 08/01/162D 3D TSV
US9169260 399 Amidopyrazole inhibitors of interleukin receptor-associated kinases MERCK SHARP & DOHME CORP. 08/01/162D 3D TSV
US9173879 6 Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a ]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof Bristol-Myers Squibb Company 08/01/162D 3D TSV
US9173869 43 Mediators of hedgehog signaling pathways, compositions and uses related thereto CURIS, INC. 08/01/162D 3D TSV
US9169246 207 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof SANOFI 08/01/162D 3D TSV
US9073941 179 Compounds and methods for treating tuberculosis infection Academia Sinica 07/26/162D 3D TSV
US9169224 209 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase Janssen Pharmaceutica NV 07/26/162D 3D TSV
US9169243 45 Apoptosis signal-regulating kinase inhibitors Gilead Sciences, Inc. 07/25/162D 3D TSV
US9169209 118 Compounds and compositions for the inhibition of NAMPT FORMA TM, LLC 07/25/162D 3D TSV
US9169252 645 Heteroaryl substituted nicotinamide compounds Bristol-Myers Squibb Company 07/25/162D 3D TSV
US9169259 92 Imidazopyridazine compounds HOFFMANN-LA ROCHE INC. 07/25/162D 3D TSV
US9169240 92 Ketone linked benzothiazole inhibitors of endothelial lipase Bristol-Myers Squibb Company 07/25/162D 3D TSV
US9079895 129 Morpholino compounds, uses and methods University of Dundee 07/25/162D 3D TSV
US9169234 24 Sepiapterin reductase inhibitors for the treatment of pain Children's Medical Center Corporation 07/25/162D 3D TSV
US9163017 17 Anti-viral compounds ABBVIE INC. 07/18/162D 3D TSV
US9168247 6 Beta carboline derivatives useful in the treatment of proliferative disorders FACULTES UNIVERSITAIRES NOTRE DAME DE LA PAIX; UNIVERSITE LIBRE BRUXELLES 07/18/162D 3D TSV
US9163012 94 Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 Vitae Pharmaceuticals, Inc. 07/18/162D 3D TSV
US9163011 106 Oxazine derivatives and their use in the treatment of disease NOVARTIS AG 07/18/162D 3D TSV
US9163042 24 Prodrugs of pyridone amides useful as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED 07/18/162D 3D TSV
US9163015 90 Pyrazolopyridine, pyrarolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction Vanderbilt University 07/18/162D 3D TSV
US9169205 200 Pyrrolidine derivatives, pharmaceutical compositions and uses thereof Boehringer Ingelheim International GmbH 07/18/162D 3D TSV
US9163021 236 Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors Pfizer Limited 07/18/162D 3D TSV
US9168248 27 Spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase Merck Canada Inc. 07/18/162D 3D TSV
US9163040 1 Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors NOVARTIS AG 07/18/162D 3D TSV
US9163013 34 Use of 1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. 07/18/162D 3D TSV
US9162979 50 1,5-Diary1-2-alkylpyrrole-3-substituted nitro esters, selective COX-2 inhibitors and nitric oxide donors ROTTAPHARM BIOTECH S.R.L. 07/11/162D 3D TSV
US9161945 2 4-isopropyl-6-methoxyphenyl glucitol compound TAISHO PHARMACEUTICAL CO., LTD. 07/11/162D 3D TSV
US9163003 106 4-piperidinyl compounds for use as tankyrase inhibitors NOVARTIS AG 07/11/162D 3D TSV
US9163007 94 5-substituted indazoles as kinase inhibitors AbbVie Inc. 07/11/162D 3D TSV
US9169182 4 Chrysophaentin analogs that inhibit FtsZ protein THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 07/11/162D 3D TSV
US9162991 55 Cinnamoyl inhibitors of transglutaminase University of Ottawa 07/11/162D 3D TSV
US9156822 144 Functionally selective ligands of dopamine D2 receptors The University of North Carolina at Chapel Hill 07/11/162D 3D TSV
US9163010 3 Indolinone protein kinase inhibitors Beta Pharma, Inc. 07/11/162D 3D TSV
US9163008 122 Pyrimidines as sodium channel blockers Purdue Pharma, L.P. 07/11/162D 3D TSV
US9161939 7 Pyrrolo[2,3-d]pyrimidine compounds Zoetis Services LLC 07/11/162D 3D TSV
US9168255 39 Quinazoline compounds as sodium channel blockers Purdue Pharma L.P. 07/11/162D 3D TSV
US9162983 5 Reactivators of organophosphorous inhibited acetylcholinesterase SOUTHWEST RESEARCH INSTITUTE 07/11/162D 3D TSV
US9156845 422 4-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibitors Pfizer Inc. 06/30/162D 3D TSV
US9161922 34 Amine oxidase inhibitors Case Western Reserve University 06/30/162D 3D TSV
US9156856 44 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases AbbVie Inc. 06/30/162D 3D TSV
US9156831 41 Chemical compounds AstraZeneca AB 06/30/162D 3D TSV
US9156829 308 Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonists TAKEDA PHARMACEUTICAL COMPANY LIMITED 06/30/162D 3D TSV
US9161924 6 Factor IXa inhibitors Merck Sharp & Dohme Corp. 06/30/162D 3D TSV
US9156830 87 Heterocyclic compounds SHIONOGI & CO., LTD. 06/30/162D 3D TSV
US9156852 39 Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases HANMI PHARM. CO., LTD 06/30/162D 3D TSV
US9156848 4 Treating diabetes with dipeptidyl peptidase-IV inhibitors Merck Sharp & Dohme Corp. 06/30/162D 3D TSV
US9156836 5 Tricyclic triazole compounds that modulate HSP90 activity Synta Pharmaceuticals Corp. 06/30/162D 3D TSV
US9150566 561 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-YL)picolinamide derivatives as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD. 06/20/162D 3D TSV
US9150578 174 5,8-dihydro-6H-pyrazolo[3,4-h]quinazolines as IGF-1R/IR inhibitors Boehringer Ingelheim International GmbH 06/20/162D 3D TSV
US9150526 208 Biaryl-propionic acid derivatives and their use as pharmaceuticals Sanofi 06/20/162D 3D TSV
US9155743 90 Bicyclic heterocycle compounds and their uses in therapy ASTEX THERAPEUTICS LIMITED 06/20/162D 3D TSV
US9150583 8 Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation Boehringer Ingelheim International GmbH 06/20/162D 3D TSV
US9150577 239 Heterocyclic compounds containing an indole core Boehringer Ingelheim International GmbH 06/20/162D 3D TSV
US9156811 829 N-myristoyl transferase inhibitors Univeristy of Dundee 06/20/162D 3D TSV
US9150581 30 Nicotinic receptor compounds RESEARCH TRIANGLE INSTITUTE; THE REGENTS OF THE UNIVERSITY OF MICHIGAN; VIRGINIA COMMONWEALTH UNIVERSITY 06/20/162D 3D TSV
US9150579 6 Selective PI3K delta inhibitors RHIZEN PHARMACEUTICALS SA 06/20/162D 3D TSV
US9156810 66 Treatment of inflammatory bowel disease Allergan, Inc. 06/20/162D 3D TSV
US9150519 242 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis MERCK SERONO SA 06/14/162D 3D TSV
US9145414 77 1,2,4-triazine-6-carboxamide derivative TAIHO PHARMACEUTICAL CO., LTD. 06/13/162D 3D TSV
US9149477 5 5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta ICOS Corporation 06/13/162D 3D TSV
US9145402 38 Aminopyrimidine derivatives as LRRK2 modulators Genentech, Inc. 06/13/162D 3D TSV
US9145391 266 Bipyridylaminopyridines as Syk inhibitors Merck Sharp & Dohme Corp.; Merck Canada Inc. 06/13/162D 3D TSV
US9145380 240 Bis-(sulfonylamino) derivatives for use in therapy Astrazeneca AB 06/13/162D 3D TSV
US9144538 75 Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin The Procter & Gamble Company 06/13/162D 3D TSV
US9145392 772 Imidazole amines as modulators of kinase activity Merck Patent GmbH 06/13/162D 3D TSV
US9145419 10 Imidazopyridazinyl compounds Bristol-Myers Squibb Company 06/13/162D 3D TSV
US9150527 8 Metalloenzyme inhibitor compounds Innocrin Pharmaceuticals, Inc. 06/13/162D 3D TSV
US9149492 26 Method for selectively inhibiting ACAT1 in the treatment of alzheimer's disease Trustees of Dartmouth College 06/13/162D 3D TSV
US9145354 231 Pharmaceutical compounds ASTEX THERAPEUTICS LIMITED 06/13/162D 3D TSV
US9145426 38 Pyrrolidine-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 06/13/162D 3D TSV
US9145412 77 Selective HDAC1 and HDAC2 inhibitors ACETYLON PHARMACEUTICALS, INC. 06/13/162D 3D TSV
US9145418 10 Substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-ones as protein kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 06/13/162D 3D TSV
US9145408 44 Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators Purdue Pharma L.P.; Shionogi & Co., Ltd. 06/13/162D 3D TSV
US9150544 176 Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application Sanofi 06/13/162D 3D TSV
US9150546 325 Triazine derivative and pharmaceutical composition comprising the same SHIONOGI & CO., LTD. 06/13/162D 3D TSV
US9139578 26 Amide or urea containing benzothiazole inhibitors of endothelial lipase Bristol-Myers Squibb Company 06/06/162D 3D TSV
US9139593 21 Azetidine compounds, compositions and methods of use HOFFMANN-LA ROCHE INC. 06/06/162D 3D TSV
US9138393 75 Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin The Procter & Gamble Company 06/06/162D 3D TSV
US9139568 167 Heterocyclic carboxamides as modulators of kinase activity Merck Patent GmbH 06/06/162D 3D TSV
US9139585 51 Inhibitors of the Renal Outer Medullary Potassium channel Merck Sharp & Dohme Corp. 06/06/162D 3D TSV
US9138431 13 Methods of treatment of histamine H-4 receptor-related pruritus BRIDGE PHARMA, INC. 06/06/162D 3D TSV
US9138494 8 Radiolabeled PDE10A ligands AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG 06/06/162D 3D TSV
US9139529 80 Substituted quinoxalines as sodium channel modulators VERTEX PHARMACEUTICALS INCORPORATED 06/06/162D 3D TSV
US9139577 328 Sulfoximine substituted quinazolines for pharmaceutical compositions Boehringer Ingelheim International GmbH 06/06/162D 3D TSV
US9139546 32 Tri-aryl/heteroaromatic cannabinoids and use thereof The University of Tennessee Research Foundation 06/06/162D 3D TSV
US9138423 2 Use of inhibitors of porphobilinogen deaminase in the treatment of congenital erythropoietic porphyria Asociación Centro de Investigación Cooperativa en Biociencias—CIC Biogune 06/06/162D 3D TSV
US9133180 33 Aurora and FLT3 kinases modulators SAREUM LIMITED 05/23/162D 3D TSV
US8772323 260 Benzoxazole- and tetrahydrobenzoxazole-substituted pyridazinones as GPR119 agonists Boehringer Ingelheim International GmbH 05/23/162D 3D TSV
US9133171 193 Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group Bayer Intellectual Property GmbH 05/23/162D 3D TSV
US8829029 164 Dual modulators of 5HT2A and D3 receptors Hoffmann-La Roche Inc. 05/23/162D 3D TSV
US9133183 27 Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities Deciphera Pharmaceuticals, LLC 05/23/162D 3D TSV
US9133201 12 Inhibitors of Bruton's tyrosine kinase PHARMACYCLICS, INC. 05/23/162D 3D TSV
US9133197 12 Oxidated derivatives of triazolylpurines useful as ligands of the adenosine A2A receptor and their use as medicaments SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. 05/23/162D 3D TSV
US8865745 19 Pyrazolone derivatives as PDE4 inhibitors Takeda GmbH 05/23/162D 3D TSV
US9133199 2 Pyrimidine derivatives as protein kinase inhibitors Cyclacel Limited 05/23/162D 3D TSV
US9133182 37 Selective androgen receptor modulators Radius Health, Inc. 05/23/162D 3D TSV
US9133187 85 Serine/threonine kinase inhibitors ARRAY BIOPHARMA INC.; GENENTECH, INC. 05/23/162D 3D TSV
US9132129 8 Antiviral compounds KATHOLIEKE UNIVERSITEIT LEUVEN 05/16/162D 3D TSV
US9133148 91 Carbamate compounds and of making and using same The Scripps Research Institute; Abide Therapeutics, Inc. 05/16/162D 3D TSV
US9133157 134 HIV protease inhibitors Merck Canada Inc. 05/16/162D 3D TSV
US9133134 1 Inhibitors of bruton's tyrosine kinase PHARMACYCLICS LLC 05/16/162D 3D TSV
US9132134 10 Methods for treating GI tract disorders Neurogastrx, Inc. 05/16/162D 3D TSV
US9133125 72 Morphan and morphinan analogues, and methods of use ALKERMES PHARMA IRELAND LIMITED 05/16/162D 3D TSV
US9133168 168 Pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors SANOFI 05/16/162D 3D TSV
US9133131 27 Pyrimidine diol amides as sodium channel blockers Purdue Pharma L.P. 05/16/162D 3D TSV
US9133160 15 Substituted benzimidazole and imidazopyridine compounds useful as CYP17 modulators Bristol-Meyers Squibb Company 05/16/162D 3D TSV
US9133162 13 Substituted quinoline compounds and methods of use SUNSHINE LAKE PHARMA CO., LTD.; CALITOR SCIENCES, LLC 05/16/162D 3D TSV
US9133105 4 Transcription factor modulators C&C BIOPHARMA, LLC 05/16/162D 3D TSV
US9126978 10 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties The Regents of the University of Michigan 05/09/162D 3D TSV
US9126979 24 Compounds for inhibiting the interaction of BCL2 with binding partners Novartis AG 05/09/162D 3D TSV
US9126980 90 Compounds for inhibiting the interaction of BCL2 with binding partners Novartis AG 05/09/162D 3D TSV
US9127027 37 Epoxyeicosatrienoic acid analogs and methods of making and using the same The Medical College of Wisconsin, Inc.; The Board of Regents of the University of Texas System 05/09/162D 3D TSV
US9126987 25 Inhibitors of glutaminyl cyclase PROBIODRUG AG 05/09/162D 3D TSV
US9127005 20 Isoform selective phospholipase D inhibitors Vanderbilt University 05/09/162D 3D TSV
US9126952 67 Morpholinylquinazolines Merck Patent GmbH 05/09/162D 3D TSV
US9126973 76 Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases CAYMAN CHEMICAL COMPANY, INCORPORATED 05/09/162D 3D TSV
US9126957 10 Selective glycosidase inhibitors and uses thereof MERCK SHARP & DOHME CORP.; ALECTOS THERAPEUTICS, INC. 05/09/162D 3D TSV
US9127001 68 Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them Sanofi 05/09/162D 3D TSV
US9126976 41 Substituted benzopiperazines as CETP inhibitors Merck Sharp & Dohme Corp. 05/09/162D 3D TSV
US9125915 17 Antitumor agent Mitsubishi Tanabe Pharma Corporation 05/02/162D 3D TSV
US9125913 853 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases AbbVie Inc. 05/02/162D 3D TSV
US9126948 14 Pyrimidine-4,6-diamine derivatives as PI3K inhibitors Incyte Holdings Corporation; Incyte Corporation 05/02/162D 3D TSV
US9120812 515 Pyrimidooxazocine derivatives as mTOR-inhibitors Sanofi 05/02/162D 3D TSV
US9120838 4 Saccharide conjugates Curators of the University of Missouri 05/02/162D 3D TSV
US9120808 141 Substituted clavulanic acid NABRIVA THERAPEUTICS AG 05/02/162D 3D TSV
US9126947 6 Substituted pyridazine carboxamide compounds Xcovery Holding Company LLC 05/02/162D 3D TSV
US9126931 266 Tetracyclic compound Chugai Seiyaku Kabushiki Kaisha 05/02/162D 3D TSV
US9126941 39 Treatment of hyperproliferative disorders with diarylhydantoin compounds The Regents of the University of California 05/02/162D 3D TSV
US9120798 50 Amino-heteroaryl 7-hydroxy-spiropiperidine indolinyl antagonists of P2Y1 receptor Bristol-Myers Squibb Company 04/25/162D 3D TSV
US9120769 172 Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline Boehringer-Ingelheim International GmbH 04/25/162D 3D TSV
US9120771 46 Azetidine derivative and antidepressant composition including the same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 04/25/162D 3D TSV
US9120772 6 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases GALDERMA RESEARCH & DEVELOPMENT 04/25/162D 3D TSV
US9120780 37 Indole or indazole derivative or salt thereof TAIHO PHARMACEUTICAL CO., LTD. 04/25/162D 3D TSV
US9120791 119 Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD 04/25/162D 3D TSV
US9120797 66 Process for preparing spirocyclic cyclohexane compounds, compositions containing such compounds and method of using such compounds Gruenenthal GmbH 04/25/162D 3D TSV
US9120785 12 Pyridyl aminopyridines as Syk inhibitors Merck Sharp & Dohme Corp. 04/25/162D 3D TSV
US9120781 7 Selective glycosidase inhibitors and uses thereof Simon Fraser University; Merck Sharp & Dohme Corp.; Alectos Therapeutics Inc. 04/25/162D 3D TSV
US9120807 28 Thienopyrimidine compounds Vernalis (R&D) Ltd. 04/25/162D 3D TSV
US9120786 14 Triazine carboxamides as sodium channel blockers Purdue Pharma, L.P. 04/25/162D 3D TSV
US9115121 70 1,3,5-triazine-2-amine derivatives, preparation thereof and diagnostic and therapeutic use thereof Sanofi 04/18/162D 3D TSV
US9119845 20 Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase Amicus Therapeautics, Inc. 04/18/162D 3D TSV
US9115122 39 Non-ATP dependent inhibitors of extracellular signal-regulated kinase (ERK) UNIVERSITY OF MARYLAND, BALTIMORE 04/18/162D 3D TSV
US9120744 43 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism THE REGENTS OF THE UNIVERSITY OF MICHIGAN; EASTERN MICHIGAN UNIVERSITY 04/18/162D 3D TSV
US9120752 40 Pyridine compounds as sodium channel blockers Purdue Pharma, L.P. 04/18/162D 3D TSV
US9120749 650 Quinoline derivatives and MELK inhibitors containing the same ONCOTHERAPY SCIENCE, INC. 04/18/162D 3D TSV
US9120761 34 Selective FAK inhibitors Cancer Therapeutics CRC PTY LTD 04/18/162D 3D TSV
US9120756 63 Substituted phenylureas and phenylamides as vanilloid receptor ligands Gruenenthal GmbH 04/18/162D 3D TSV
US9120745 4 Triazole compounds that modualte HSP90 activity Synta Pharmaceuticals Corp. 04/18/162D 3D TSV
US9115089 2 Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds CONFLUENCE LIFE SCIENCES, INC. 04/12/162D 3D TSV
US9115140 33 Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof SANOFI 04/12/162D 3D TSV
US9115126 10 1H-[1,2,3]triazolo[4,5-c]pyridine-4-carbonitrile derivatives Merck Sharp & Dohme B.V. 04/11/162D 3D TSV
US9096593 403 Compounds and methods for kinase modulation, and indications therefor Plexxikon Inc. 04/11/162D 3D TSV
US9115083 75 Compounds from Antrodia cinnamomea and use thereof SIMPSON BIOTECH CO., LTD. 04/11/162D 3D TSV
US9115085 1 Crystalline forms of a prolyl hydroxylase inhibitor FIBROGEN, INC. 04/11/162D 3D TSV
US9115082 9 Dipeptidyl-peptidase-IV inhibitors for treatment of type 2 diabetes complex with hypertension TBA 04/11/162D 3D TSV
US9115116 27 Dual action inhibitors against histone deacetylases and 3-hydroxy-3-methylglutaryl coenzyme a reductase Academia Sinica; National Taiwan University 04/11/162D 3D TSV
US9115144 5 Fused heterocyclic derivative and pharmaceutical use thereof KISSEI PHARMACEUTICAL CO., LTD. 04/11/162D 3D TSV
US9115102 45 N-[2-hydroxycarbamoyl-2-(piperazinyl) ethyl] benzamide compounds, their preparation and their use as TACE inhibitors GALDERMA RESEARCH & DEVELOPMENT 04/11/162D 3D TSV
US9115117 280 Substituted piperidine compounds and their use as orexin receptor modulators JANSSEN PHARMACEUTICA NV 04/11/162D 3D TSV
US9102669 100 Substituted piperidinyl-pyridazinyl derivatives useful as SCD 1 inhibitors Janssen Pharmaceutica NV 04/05/162D 3D TSV
US9102686 152 5,6,7,8,9,10-hexahydro-6,10-epimino[1,2,4]triazolo[4,3-a]azocines as P2X7 modulators Janssen Pharmaceutica NV 04/04/162D 3D TSV
US9102591 244 Benzamides H. Lundbeck A/S 04/04/162D 3D TSV
US9102637 93 Bicyclic thiazole compounds CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER 04/04/162D 3D TSV
US9102622 63 Fatty acid amide hydrolase inhibitors University of Connecticut 04/04/162D 3D TSV
US9096627 6 Hydroxamic acid derivatives Purdue Pharmaceutical Products L.P. 04/04/162D 3D TSV
US9102599 15 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases Bristol-Myers Squibb Company 04/04/162D 3D TSV
US9114126 10 Na/K-ATPase ligands, ouabain antagonists, assays and uses thereof THE UNIVERSITY OF TOLEDO 04/04/162D 3D TSV
US9115061 17 Naphthalene-based inhibitors of anti-apoptotic proteins BURNHAM INSTITUTE FOR MEDICAL RESEARCH 04/04/162D 3D TSV
US9102670 445 Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors KUDOS PHARMACEUTICALS LIMITED 04/04/162D 3D TSV
US9102656 12 Use of rosuvastatin lactols as medicaments RedX Pharma Limited 04/04/162D 3D TSV
US9096559 134 4-carboxybenzylamino derivatives as histone deacetylase inhibitors Merck Sharp & Dohme Corp. 03/28/162D 3D TSV
US9096595 51 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin D2 receptor modulators Actelion Pharmaceuticals Ltd 03/28/162D 3D TSV
US9096579 258 Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments Boehringer Ingelheim International GmbH 03/28/162D 3D TSV
US9238653 54 Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM; MMV MEDICINES FOR MALARIA VENTURE; UNIVERSITY OF WASHINGTON 03/28/162D 3D TSV
US9096601 108 Arylamino purine derivatives, preparation method and pharmaceutical use thereof CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.; Sichuan University 03/28/162D 3D TSV
US9096580 5 Benzofuran derivatives for the treatment of hepatitis C Bristol-Myers Squibb Company 03/28/162D 3D TSV
US9096589 112 Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors H. Lundbeck A/S 03/28/162D 3D TSV
US9096541 28 Inhibition of memapsin 1 cleavage in the treatment of diabetes Oklahoma Medical Research Foundation; Purdue Research Foundation 03/28/162D 3D TSV
US9096594 15 Kinase inhibitors and methods of use thereof The Broad Institute, Inc.; The General Hospital Corporation; Dana-Farber Cancer Institute, Inc. 03/28/162D 3D TSV
US9096515 36 Methods of using cycloalkylmethylamine derivatives REVIVA PHARMACEUTICALS, INC. 03/28/162D 3D TSV
US9096596 332 P2X7 modulators JANSSEN PHARMACEUTICA NV 03/28/162D 3D TSV
US9096606 64 Quarternized buprenorphine analogs Purdue Pharma, L.P. 03/28/162D 3D TSV
US9096549 46 Selective HDAC3 inhibitors ACETYLON PHARMACEUTICALS, INC. 03/28/162D 3D TSV
US9089569 190 1,2,6-substituted benzimidazoles as flap modulators JANSSEN PHARMACEUTICA NV 03/21/162D 3D TSV
US9090564 130 5-alkynyl-pyridines Boehringer Ingelheim International GmbH 03/21/162D 3D TSV
US9090562 334 Aryl- or heteroaryl-substituted benzene compounds Epizyme, Inc. 03/21/162D 3D TSV
US9090628 126 Benzoxazepin compounds selective for PI3K P110 delta and methods of use GENENTECH, INC. 03/21/162D 3D TSV
US9090657 22 Compound and methods for its production NEUROVIVE PHARMACEUTICAL AB 03/21/162D 3D TSV
US9090596 84 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies GALDERMA RESEARCH & DEVELOPMENT 03/21/162D 3D TSV
US9090589 25 Specific nNOS inhibitors for the therapy and prevention of human melanoma Northwestern University; The Regents of the University of California 03/21/162D 3D TSV
US9090618 172 Substituted benzimidazole-type piperidine compounds and uses thereof Purdue Pharma L.P. 03/21/162D 3D TSV
US9085584 356 Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disorders Boehringer Ingelheim International GmbH 03/21/162D 3D TSV
US9090625 9 Therapeutic pyrazolyl thienopyridines THESAN PHARMACEUTICALS, INC. 03/21/162D 3D TSV
US9085572 10 4-(pyridin-3-yl)-2(pyridin-2yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases Bayer Intellectual Property GmbH 03/16/162D 3D TSV
US9085531 117 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin Albany Molecular Research, Inc.; Bristol-Myers Squibb Company 03/14/162D 3D TSV
US9085555 773 Complement pathway modulators and uses thereof NOVARTIS AG 03/14/162D 3D TSV
US9085549 48 Compounds for the treatment of neurodegenerative diseases PROTEOTECH INC 03/14/162D 3D TSV
US9079902 124 Heteroaryl sodium channel inhibitors AMGEN INC. 03/14/162D 3D TSV
US9085571 30 Nonpeptide HIV-1 protease inhibitors Purdue Research Foundation 03/14/162D 3D TSV
US9085576 846 Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use AMGEN INC. 03/14/162D 3D TSV
US9085540 31 Pyrazinecarboxamide compound Astellas Pharma Inc. 03/14/162D 3D TSV
US9079913 185 Spiro-oxindole MDM2 antagonists THE REGENTS OF THE UNIVERSITY OF MICHIGAN 03/14/162D 3D TSV
US9079929 29 Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors Bristol-Myers Squibb Company 03/14/162D 3D TSV
US9073940 429 Tricyclic pyrazol amine derivatives MERCK SERONO SA 03/09/162D 3D TSV
US9079866 833 Flap modulators JANSSEN PHARMACEUTICA NV 03/07/162D 3D TSV
US9079834 11 HIV protease inhibitors Merck Canada Inc. 03/07/162D 3D TSV
US9073926 105 Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core Boehringer Ingelheim International GmbH 03/07/162D 3D TSV
US9073939 7 Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof Bayer Intellectual Property GmbH 03/07/162D 3D TSV
US9073931 108 Liver X receptor modulators Vitae Pharmaceuticals, Inc. 03/07/162D 3D TSV
US9079852 20 NMDA receptor antagonists for neuroprotection Emory University; NeurOp, Inc. 03/07/162D 3D TSV
US9073936 8 Organic compounds INTRA-CELLULAR THERAPIES, INC. 03/07/162D 3D TSV
US9079880 163 Rho kinase inhibitors Boehringer Ingelheim International GmbH 03/07/162D 3D TSV
US9079868 1 Selective glycosidase inhibitors and uses thereof Simon Fraser University 03/07/162D 3D TSV
US9079906 27 Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments Sanofi 03/07/162D 3D TSV
US9073893 60 3-Oxo-2,3-dihydro-1H-indazole-4-carboxamide derivatives as PARP-1 inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 02/29/162D 3D TSV
US9073870 181 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use Boehringer Ingelheim International GmbH 02/29/162D 3D TSV
US9073917 27 Anti-cancer compound and pharmaceutical composition containing the same SANOFI 02/29/162D 3D TSV
US9073925 10 Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof Albany Molecular Research, Inc. 02/29/162D 3D TSV
US9073881 153 Benzoic acid derivatives HOFFMANN-LA ROCHE INC. 02/29/162D 3D TSV
US9073876 335 Flap modulators JANSSEN PHARMACEUTICA NV 02/29/162D 3D TSV
US9073882 9 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 02/29/162D 3D TSV
US9073869 37 Method of using substituted 2-Aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C Boehringer Ingelheim International GmbH 02/29/162D 3D TSV
US9073911 108 Pyrazole derivatives HOFFMANN-LA ROCHE INC. 02/29/162D 3D TSV
US9073922 368 Pyrrolo[2,3-B]pyridine CDK9 kinase inhibitors AbbVie, Inc. 02/29/162D 3D TSV
US9073906 44 Sulfamide derivative having an adamantyl group and its pharmaceutically acceptable salt KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY 02/29/162D 3D TSV
US9067924 24 1,4 thiazepines/sulfones as BACE1 and/or BACE2 inhibitors HOFFMANN-LA ROCHE INC. 02/22/162D 3D TSV
US9067937 113 1,5-naphthyridine derivatives and MELK inhibitors containing the same OncoTherapy Science, Inc. 02/22/162D 3D TSV
US9067931 20 2-heteroaryl carboxamides BAYER INTELLECTUAL PROPERTY GMBH 02/22/162D 3D TSV
US9067949 216 Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia Albany Molecular Research, Inc. 02/22/162D 3D TSV
US9067922 243 Chemical compounds Pfizer Limited 02/22/162D 3D TSV
US9073853 157 Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists SANOFI 02/22/162D 3D TSV
US9062043 371 Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators SENHWA BIOSCIENCES, INC. 02/22/162D 3D TSV
US9073821 60 Hydroxamic acid derivative TAISHO PHARMACEUTICAL CO., LTD; TOYAMA CHEMICAL CO., LTD. 02/22/162D 3D TSV
US9067935 114 Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators Janssen Pharmaceutica, NV 02/22/162D 3D TSV
US9073833 17 Oxime-based compound, pharmaceutical composition containing the same and method for preparing the same Chang Gung University 02/22/162D 3D TSV
US9067945 10 Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes Boehringer Ingehleim International GmbH 02/22/162D 3D TSV
US9067917 220 1,2,5-substituted benzimidazoles as FLAP modulators Janssen Pharmaceutica NV 02/16/162D 3D TSV
US9067871 405 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG; AbbVie Inc. 02/16/162D 3D TSV
US9062066 13 Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases and pharmaceutical composition containing same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 02/16/162D 3D TSV
US9066954 107 Fused heterocyclic derivatives and methods of use Amgen Inc. 02/16/162D 3D TSV
US9067888 20 Inhibitors of protein kinases AstraZeneca AB 02/16/162D 3D TSV
US9062070 238 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 02/16/162D 3D TSV
US9062059 20 Pyrimidine PDE10 inhibitors Merck Sharp & Dohme Corp. 02/16/162D 3D TSV
US9062078 702 Substituted 7-azabicyles and their use as orexin receptor modulators JANSSEN PHARMACEUTICA NV 02/16/162D 3D TSV
US9062060 11 Substituted imidazo[2,1-A]isoindoles as PDE10 inhibitors H. Lundbeck A/S 02/16/162D 3D TSV
US9067914 241 Tropomyosin-related kinase (TRK) inhibitors Genzyme Corporation 02/16/162D 3D TSV
US9061041 6 2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases Merck Sharp & Dohme Corp. 02/09/162D 3D TSV
US9062004 58 Cannabinoid-2 agonists Allergan, Inc. 02/09/162D 3D TSV
US9062048 173 Cyclohexyl-azetidinyl antagonists of CCR2 Janssen Pharmaceutica NV 02/09/162D 3D TSV
US9062026 89 Fused pyrimidines and substituted quinazolines as inhibitors of p97 Cleave Biosciences, Inc. 02/09/162D 3D TSV
US9056859 11 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 02/09/162D 3D TSV
US9061023 2 Management and treatment of benign prostatic hyperplasia CSIR 02/09/162D 3D TSV
US9056865 149 Pyridine-2-derivatives as smoothened receptor modulators Pfizer Inc. 02/09/162D 3D TSV
US9056863 3 Substituted 2,3,5,9,9B-pentaazacyclopenta[a]naphthalenes and uses thereof H. Lundbeck A/S 02/09/162D 3D TSV
US9062045 143 Triazolopyridine compounds Novartis AG 02/09/162D 3D TSV
US9056843 460 Trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease NOVARTIS AG 02/09/162D 3D TSV
US9056847 4 Activity based probes (ABPs) interacting with glycosidases ACADEMISCH MEDISCH CENTRUM BIJ UNIVERSITEIT VAN AMSTERDAM 01/25/162D 3D TSV
US9051313 18 Apoptosis signal-regulating kinase inhibitors Gildead Sciences, Inc. 01/25/162D 3D TSV
US9056836 11 Benzomorphan analogs and the use thereof Purdue Pharma L.P. 01/25/162D 3D TSV
US9051321 28 Heterocyclic acrylamides and their use as pharmaceuticals FAB PHARMA S.A.S. 01/25/162D 3D TSV
US9056857 7 Methods for treating or preventing cancer and neurodegenerative diseases SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 01/25/162D 3D TSV
US9056832 152 Pyridine compounds and the users thereof Purdue Pharma L.P. 01/25/162D 3D TSV
US9051279 174 Substituted isoquinolinones and quinazolinones Novartis AG 01/25/162D 3D TSV
US9051311 173 Sulfamide sodium channel inhibitors AMGEN INC. 01/25/162D 3D TSV
US9051280 10 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG; AbbVie Inc. 01/25/162D 3D TSV
US9051329 8 Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors Merck Sharp & Dohme Corp. 01/25/162D 3D TSV
US9108973 73 3,5-disubstituted alkynylbenzene compound and salt thereof Taiho Pharmaceutical Co., Ltd. 01/19/162D 3D TSV
US9108978 16 Antimicrobial compounds Monash University; Adelaide Research & Innovation Pty Ltd 01/19/162D 3D TSV
US9108983 174 Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD 01/19/162D 3D TSV
US9108984 2 Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors Incyte Corporation; Incyte Holdings Corporation 01/19/162D 3D TSV
US9108950 12 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitors Respivert, Ltd. 01/18/162D 3D TSV
US9108956 11 Cyclic ether DGAT1 inhibitorscyclic ether DGAT1 inhibitors NOVARTIS AG 01/18/162D 3D TSV
US9051265 89 N-benzylindole modulators of PPARG The Scripps Research Institute 01/18/162D 3D TSV
US9051270 160 Pyridone amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED 01/18/162D 3D TSV
US9051240 7 Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators Newron Pharmaceuticals S.P.A. 01/18/162D 3D TSV
US9045501 28 5-HT3 receptor modulators, methods of making, and use thereof Albany Molecular Research, Inc. 01/11/162D 3D TSV
US9108903 76 Amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED 01/11/162D 3D TSV
US9107954 14 Bivalent ligands for the treatment of neurological disorders Virginia Commonwealth University 01/11/162D 3D TSV
US9107923 81 Heteroaromatic compounds and their use as dopamine D1 ligands Pfizer Inc. 01/11/162D 3D TSV
US9045498 25 Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Pfizer Inc. 01/11/162D 3D TSV
US9045500 32 Inhibitors of beta-secretase Vitae Pharmaceuticals, Inc. 01/11/162D 3D TSV
US9108947 18 Inhibitors of the Renal Outer Medullary Potassium channel Merck Sharp & Dohme Corp. 01/11/162D 3D TSV
US9045524 160 Selective caspase inhibitors and uses thereof NOVAGENESIS FOUNDATION 01/11/162D 3D TSV
US9108951 16 Substituted 5,6,7,8-tetrahydro-1,6-naphthyridines as factor XIa inhibitors Bristol-Myers Squibb Company 01/11/162D 3D TSV
US9108905 19 TRPA1 antagonists AbbVie Inc. 01/11/162D 3D TSV
US9045468 186 2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin Albany Molecular Research, Inc.; Bristol-Myers Squibb Company 12/21/152D 3D TSV
US9045389 9 Biphenyl derivatives useful as glucagon receptor antagonists Janssen Pharmaceutica NV 12/21/152D 3D TSV
US9040694 20 Compounds and methods useful for directing stem cell differentiation Vanderbilt University 12/21/152D 3D TSV
US9040693 15 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof KISSEI PHARMACEUTICAL CO., LTD. 12/21/152D 3D TSV
US9040727 36 Histone deacetylase inhibitor of benzamides and use thereof Shanghai Institute of Pharmaceutical Industry; Sinopharm A-Think Pharmaceutical Co., Ltd.; Sinopharm A-Think Medical and Pharmaceutical Research & Development (Beijing) Co., Ltd. 12/21/152D 3D TSV
US9040691 47 Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors BAYER INTELLECTUAL PROPERTY GMBH 12/21/152D 3D TSV
US9040714 139 IRE-1α inhibitors MannKind Corporation 12/21/152D 3D TSV
US9045483 13 Inhibition of small ubiquitin-like modifier enzymes with substituted pyrrolo[2,3-b]quinoxalines City of Hope; Sanford-Burnham Medical Research Institute 12/21/152D 3D TSV
US9045459 3 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG; AbbVie Inc. 12/21/152D 3D TSV
US9040717 10 Pyrazole-amide compounds and pharmaceutical use thereof JAPAN TOBACCO INC. 12/21/152D 3D TSV
US9040518 72 Chemical compounds GlaxoSmithKline LLC 12/14/152D 3D TSV
US9040528 203 Chemical compounds 542 AstraZeneca AB 12/14/152D 3D TSV
US9040501 5 Compositions and methods for treating cancer Otsuka Pharmaceutical Co., Ltd. 12/14/152D 3D TSV
US9040663 202 Melanocortin receptor-specific peptides AstraZeneca AB 12/14/152D 3D TSV
US9040509 6 Method of treating human skin and a skin care composition for use in such a method Pantarhei Bioscience B.V. 12/14/152D 3D TSV
US9035059 157 Nitrogen-containing condensed heterocyclic compound TAISHO PHARMACEUTICAL CO., LTD. 12/14/152D 3D TSV
US9035074 168 Pyrrolo[2,3-D]pyrimidine derivatives Pfizer Inc. 12/14/152D 3D TSV
US9040542 2 Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pryimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea VERTEX PHARMACEUTICALS INCORPORATED 12/14/152D 3D TSV
US9040534 279 [1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulators Janssen Pharmaceutica NV 12/14/152D 3D TSV
US9034921 203 Diphenylmethane derivatives as SGLT2 inhibitors GREEN CROSS CORPORATION 12/08/152D 3D TSV
US9035066 3 Method of using 4,5,6,7-tetrahydroimidazo[4,5-C]pyridine compounds Proximagen Limited 12/08/152D 3D TSV
US9035062 3 Process for preparing a compound useful for producing an optically active diazabicyclooctane compound MEIJI SEIKA PHARMA CO., LTD. 12/08/152D 3D TSV
US9034856 51 17-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative Bayer Intellectual Property GmbH 12/07/152D 3D TSV
US9034886 5 4-aminoquinazoline derivatives and uses thereof Shanghai Institute of Pharmaceutical Industry; Jiangsu Hengyi Pharmaceutical Co., Ltd. 12/07/152D 3D TSV
US9034574 20 Agents for reversing epigenetic silencing of genes The Johns Hopkins University 12/07/152D 3D TSV
US9034899 81 Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof Albany Molecular Research, Inc. 12/07/152D 3D TSV
US9034874 20 Carbamate/urea derivatives NOVARTIS AG 12/07/152D 3D TSV
US9034897 44 Indanyl-substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-C]pyridines, their use as medicament, and pharmaceutical preparations comprising them SANOFI 12/07/152D 3D TSV
US9034907 36 Inhibitors of glutaminyl cyclase Probiodrug AG 12/07/152D 3D TSV
US9034866 815 Tricyclic compounds and methods of use therefor Genentech, Inc. 12/07/152D 3D TSV
US9029399 54 17α-hydroxylase/C17,20-lyase inhibitors Novartis AG 11/23/152D 3D TSV
US9029364 34 2,5-disubstituted thiomorpholine orexin receptor antagonists Merck Sharp & Dohme Corp. 11/23/152D 3D TSV
US9029393 22 Adenosine receptor ligands and uses thereof Kaldi Pharma, SAS 11/23/152D 3D TSV
US9029381 55 Cyclopropyl amide derivatives Astrazeneca AB 11/23/152D 3D TSV
US9029362 23 Iminothiadiazine dioxide compounds as brace inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 11/23/152D 3D TSV
US9034303 10 Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereof TBA 11/23/152D 3D TSV
US9034854 6 Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy PANTARHEI BIOSCIENCE B.V. 11/23/152D 3D TSV
US9029401 58 Sorafenib derivatives as sEH inhibitors The Regents of the University of California 11/23/152D 3D TSV
US9029370 276 Substituted benzamide derivatives Hoffmann-La Roche Inc. 11/23/152D 3D TSV
US9023767 2 γ-Secretase substrates and methods of use Memorial Sloan-Kettering Cancer Center 11/16/152D 3D TSV
US9023882 212 5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same Kissei Pharmaceutical Co., Ltd. 11/16/152D 3D TSV
US9029367 5 BACE inhibitors Eli Lilly and Company 11/16/152D 3D TSV
US9023865 687 Compounds that are ERK inhibitors Merck Sharp & Dohme Corp. 11/16/152D 3D TSV
US9024044 162 Heteroarylcarboxylic acid ester derivative Ajinomoto Co., Inc. 11/16/152D 3D TSV
US9029360 36 Pyrazolopyrimidines as metabotropic glutamate 5 receptor antagonists Boehringer Ingelheim International GmbH 11/16/152D 3D TSV
US9023849 22 Substituted fused imidazoles and pyrazoles and use thereof Bayer Intellectual Property GmbH 11/16/152D 3D TSV
US9029356 12 Substituted indazole derivatives active as kinase inhibitors Nerviano Medical Sciences S.R.L. 11/16/152D 3D TSV
US9018371 27 Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient FM Therapeutics Co., Ltd.; The United States of America, As Represented by the Secretary, Department of Health and Human Services, The Office of Technology Transfer, National Institutes of Health 11/11/152D 3D TSV
US9018381 66 Chemical compounds AstraZeneca AB 11/11/152D 3D TSV
US9023354 43 Combination therapy with MDM2 and EFGR inhibitors TBA 11/11/152D 3D TSV
US9018217 124 Phenylimidazole derivatives as PDE10A enzyme inhibitors H. Lundbeck A/S 11/11/152D 3D TSV
US9029559 503 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals SANOFI 11/11/152D 3D TSV
US9018213 12 Alicyclic[c] benzopyrone derivatives and uses thereof Huazhong University of Science & Technology; NHWA Pharma. Corporation 11/02/152D 3D TSV
US9018214 370 Bicyclic heterocycle compounds and their uses in therapy Astex Therapeutics Limited 11/02/152D 3D TSV
US9011882 20 Dimethylarginine dimethylaminohydrolase inhibitors and methods of use thereof The Board of Trustees of the Leland Stanford Junior University 11/02/152D 3D TSV
US9018255 7 Esters of (acyloxymethyl)acrylamide, a pharmaceutical composition containing them, and their use as inhibitors of the thioredoxin—thioredoxin reductase system Instytut Chemii Organicznej Polskiej Akademii Nauk; Warszawski Uniwersytet Medyczny 11/02/152D 3D TSV
US9012461 132 FAK inhibitors Cancer Therapeutics CRC Pty Ltd 11/02/152D 3D TSV
US9018234 8 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof Bayer Intellectual Property GmbH 11/02/152D 3D TSV
US9018391 16 Inhibitors of beta-secretase Boehringer Ingelheim International GmbH; Vitae Pharmaceuticals, Inc. 11/02/152D 3D TSV
US9018211 9 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 11/02/152D 3D TSV
US9012475 26 Method for enhancing anti-tumor effect of a microtubule-targeting drug, and a method for treatment of tumor Taiho Pharmaceutical Co., Ltd. 11/02/152D 3D TSV
US9012651 291 TRPV3 modulators AbbVie Inc. 11/02/152D 3D TSV
US9006269 19 Azetidine derivatives Vernalis (R&D) Ltd. 10/26/152D 3D TSV
US9006454 111 Dihydroorotate dehydrogenase inhibitors Merck Serono S.A. 10/26/152D 3D TSV
US9006244 14 Liver X receptor modulators Vitae Pharmaceuticals, Inc. 10/26/152D 3D TSV
US9006283 6 Methods of modifying amyloid β oligomers using non-peptidic compounds Acumen Pharmaceuticals, Inc. 10/26/152D 3D TSV
US9006268 10 Prolylcarboxypeptidase inhibitors Merck Sharp & Dohme Corp. 10/26/152D 3D TSV
US9006232 98 Pyrimidone derivatives Mitsubishi Tanabe Pharma Corporation 10/26/152D 3D TSV
US9006282 20 Rosuvastatin and atorvastatin derivatives Redx Pharma Limited 10/26/152D 3D TSV
US9006249 13 Substituted aminobutyric derivatives as neprilysin inhibitors Novartis AG 10/26/152D 3D TSV
US9006242 15 Substituted benzene compounds Epizyme, Inc. 10/26/152D 3D TSV
US9006246 15 Tetrahydrocarboline derivative Ono Pharmaceutical Co., Ltd. 10/26/152D 3D TSV
US9000182 41 2H-imidazol-4-amine compounds and their use as BACE inhibitors AstraZeneca AB 10/19/152D 3D TSV
US9000185 18 Cycloalkyl ether compounds and their use as BACE inhibitors AstraZeneca AB 10/19/152D 3D TSV
US9000183 21 Cyclohexane-1,2′-indene-1′,2″-imidazol compounds and their use as BACE inhibitors Astrazeneca AB 10/19/152D 3D TSV
US9000184 31 Cyclohexane-1,2′-naphthalene-1′,2″-imidazol compounds and their use as BACE inhibitors AstraZeneca AB 10/19/152D 3D TSV
US8999957 459 Heterocyclic compounds as ERK inhibitors Merck Sharp & Dohme Corp. 10/19/152D 3D TSV
US9000153 43 Imidazo[4,5-c]quinolines as DNA-PK inhibitors Merck Patent GmbH 10/19/152D 3D TSV
US9000043 4 Phenoxyethoxy compounds Eli Lilly and Company 10/19/152D 3D TSV
US9000029 118 Proline sulfonamide derivatives as orexin receptor antagonists Actelion Pharmaceuticals Ltd. 10/19/152D 3D TSV
US9000044 67 Substituted naphthylacetic acids Hoffmann-La Roche Inc. 10/19/152D 3D TSV
US9006187 34 Thiophene derivative as SGLT2 inhibitor and pharmaceutical composition comprising same Green Cross Corporation 10/19/152D 3D TSV
US8999981 252 3-amido-pyrrolo[3,4-C]pyrazole-5(1H, 4H,6H) carbaldehyde derivatives Pfizer Inc.; Pfizer Products Inc. 10/12/152D 3D TSV
US9012443 827 Bicyclic aryl and heteroaryl sodium channel inhibitors Amgen Inc. 10/12/152D 3D TSV
US9000008 5 Amides of acetic and propionic acids Bayer Intellectual Property GmbH 10/05/152D 3D TSV
US9000015 42 Compounds for the treatment of addiction Gilead Sciences, Inc. 10/05/152D 3D TSV
US8999994 36 Derivatives of propargylamine having neuroprotective capacity for the treatment of Alzheimer's and Parkinson's diseases Consejo Superior de Investigaciones Cientificas; Universitat Autonoma de Barcelona; Universidad de Barcelona 10/05/152D 3D TSV
US8999980 19 Oxazine derivatives Shionogi & Co., Ltd. 10/05/152D 3D TSV
US8999982 16 Pharmaceutically active compounds as Axl inhibitors Lead Discovery Center GmbH; Max-Planck-Gesellschaft zur Förderung der Wissenschaften E.V. 10/05/152D 3D TSV
US8993808 181 Phenylcyclopropylamine derivatives and their medical use Oryzon Genomics, S.A. 10/05/152D 3D TSV
US8999998 95 Pyrazolopyrimidine JAK inhibitor compounds and methods Genentech, Inc. 10/05/152D 3D TSV
US8999975 140 Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C Boehringer Ingelheim International GmbH 10/05/152D 3D TSV
US8999955 14 Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological Centre National de la Recherche Scientifique 10/05/152D 3D TSV
US8993616 113 (aza)indole derivative and use thereof for medical purposes Kissei Pharmaceutical Co., Ltd. 09/28/152D 3D TSV
US8993596 3 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics Galderma Research & Development 09/28/152D 3D TSV
US8993631 43 Method of treating contrast-induced nephropathy Novartis AG 09/28/152D 3D TSV
US8993612 10 Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer Rhizen Pharmaceuticals SA 09/28/152D 3D TSV
US8993568 6 Morpholinyl derivatives useful as MOGAT-2 inhibitors Eli Lilly and Company 09/28/152D 3D TSV
US8993586 248 N1/N2-lactam acetyl-CoA carboxylase inhibitors Pfizer Inc. 09/28/152D 3D TSV
US8993756 226 Pyrrolopyrimidines as janus kinase inhibitors Merck Sharp & Dohme Corp. 09/28/152D 3D TSV
US8993614 52 Substituted pyrrolidine-2-carboxamides F. Hoffmann-La Roche AG 09/28/152D 3D TSV
US8993765 26 Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof Albany Molecular Research, Inc. 09/28/152D 3D TSV
US8993575 12 [1,3,4] oxadiazole derivative and application thereof Huazhong University of Science & Technology; NHWA Pharma Corporation 09/28/152D 3D TSV
US8993565 161 (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors Sanofi 09/03/152D 3D TSV
US8993552 72 Compositions and methods for treatment of leukemia The Regents of The University of Michigan; University of Virginia Patent Foundation 09/03/152D 3D TSV
US8987474 133 Inhibition of Shp2/PTPN11 protein tyrosine phosphatase by NSC-87877, NSC-117199 and their analogs University of South Florida; H. Lee Moffitt Cancer Center and Research Institute, Inc. 09/03/152D 3D TSV
US8993557 10 Pyridinedione carboxamide inhibitors of endothelial lipase Bristol-Myers Squibb Company 09/03/152D 3D TSV
US8993556 18 Resorcinol derivatives as HSP90 inhibitors Nerviano Medical Sciences S.R.L. 09/03/152D 3D TSV
US8987473 72 Ring-fused compound Sato Pharmaceutical Co., Ltd. 09/03/152D 3D TSV
US8987457 595 Ring-substituted N-pyridinyl amides as kinase inhibitors Novartis AG 09/03/152D 3D TSV
US8987319 37 Selective androgen receptor modulators Radius Health, Inc. 09/03/152D 3D TSV
US8987335 35 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors University of Utah Research Foundation 09/03/152D 3D TSV
US8987445 181 Sulfonamide compounds having TRPM8 antagonistic activity Mitsubishi Tanabe Pharma Corporation 09/03/152D 3D TSV
US8987314 725 Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipase Bristol-Myers Squibb Company 08/25/152D 3D TSV
US8987272 3 Compounds and method for treatment of HIV Critical Outcome Technologies Inc. 08/25/152D 3D TSV
US8987257 68 Heterocyclic derivatives Novartis AG 08/25/152D 3D TSV
US8987313 34 Inhibitors of cytochrome P450 Gilead Sciences, Inc. 08/25/152D 3D TSV
US8987315 20 Metalloenzyme inhibitor compounds Innocrin Pharmaceuticals, Inc. 08/25/152D 3D TSV
US8981106 177 Pyrimidinecarboxamides as CXCR2 modulators Syntrix Biosystems, Inc. 08/25/152D 3D TSV
US8987268 121 Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases Bristol-Myers Squibb Company 08/25/152D 3D TSV
US8987287 25 Spirocyclic morphinans and their use Purdue Pharma L.P. 08/25/152D 3D TSV
US8987273 75 Substituted imidazo[1,2-B]pyridazines Bayer Intellectual Property GmbH 08/25/152D 3D TSV
US8987286 45 Substituted pyrimido[1,2-b]indazoles and their use as modulators of the Pi3K/Akt pathway Bayer Intellectual Property GmbH 08/25/152D 3D TSV
US8987239 20 19-nor-steroid derivatives with a 15α,16α-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives Bayer Intellectual Property GbmH 08/19/152D 3D TSV
US8980938 7 CXCR2 inhibitors Sanofi 08/19/152D 3D TSV
US8980932 40 Cancer targeting using carbonic anhydrase isoform IX inhibitors Stichting Maastricht Radiation Oncology “Maastro-Clinic”; Université Montpellier 2 Sciences et Techniques 08/19/152D 3D TSV
US8981112 25 Inhibitors of β-secretase Vitae Pharmaceuticals, Inc.; Boehringer-Ingelheim International GmbH 08/19/152D 3D TSV
US8987247 3 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders Janssen Pharmaceutica NV 08/19/152D 3D TSV
US8987242 15 Morpholinone compounds as factor IXA inhibitors Merck Sharp & Dohme Corp.; Mochida Pharmaceuticals Co., Ltd. 08/19/152D 3D TSV
US8987249 358 Substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C Boehringer Ingelheim International GmbH 08/19/152D 3D TSV
US8980954 13 Substituted cis- and trans-stilbenes as therapeutic agents STC.UNM 08/19/152D 3D TSV
US8987248 26 Substituted piperidines as Par-1 antagonists Bayer Intellectual Property GmbH 08/19/152D 3D TSV
US8987254 8 Tetrahydropyrrolothiazine compounds Eli Lilly and Company 08/19/152D 3D TSV
US8980887 7 2-aryl imidazo[1,2-a]pyridine-3-acetamide derivatives, preparation methods and uses thereof Institute of Pharmacology; Toxicology Academy of Military Medical Sciences P.L.A., China 08/10/152D 3D TSV
US8980901 5 5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta Icos Corporation 08/10/152D 3D TSV
US8980829 56 Aryl glycoside compound, preparation method and use thereof Shanghai Yingli Science and Technology Co., Ltd; Shanghai Chempartner Co., Ltd 08/10/152D 3D TSV
US8980905 10 Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors Leo Pharma A/S 08/10/152D 3D TSV
US8975415 367 Chromane compounds CoMentis, Inc. 08/10/152D 3D TSV
US8980916 3 Factor IXa inhibitors Merck Sharp & Dohme Corp.; Mochida Pharmaceutical Co., Ltd. 08/10/152D 3D TSV
US8980904 18 Heterocyclic substituted pyrimidine compound Xuanzhu Pharma Co., Ltd. 08/10/152D 3D TSV
US8975409 18 Phenyl derivative ONO Pharmaceutical Co., Ltd. 08/10/152D 3D TSV
US8975417 716 Pyrazolopyrrolidine derivatives and their use in the treatment of disease Novartis AG 08/10/152D 3D TSV
US8980906 50 Pyridonemorphinan analogs and biological activity on opioid receptors Purdue Pharma L.P. 08/10/152D 3D TSV
US8980929 14 Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes Merck Sharp & Dohme Corp. 08/10/152D 3D TSV
US8975250 13 5 oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases SANOFI 08/03/152D 3D TSV
US8975261 14 Aryloxmethyl cyclopropane derivatives as PDE10 inhibitors Merck Sharp & Dohme Corp. 08/03/152D 3D TSV
US8975249 94 Heterocyclic compounds and uses thereof Celgene Avilomics Research, Inc. 08/03/152D 3D TSV
US8975276 8 Inhibitors of PDE10 Bristol-Myers Squibb Company 08/03/152D 3D TSV
US8962860 19 Inhibitors of glutaminyl cyclase Probiodrug AG 08/03/152D 3D TSV
US8975247 27 Methods and compositions of treating a flaviviridae family viral infection The Board of Trustees of the Leland Stanford Junion University 08/03/152D 3D TSV
US8975252 2 Morpholine derivative Shanghai Pharmaceuticals Holding Co., Ltd.; Mitsubishi Tanabe Pharma Corporation 08/03/152D 3D TSV
US8975260 12 Pyridazinones, method of making, and method of use thereof Genetech, Inc; Gilead Connecticut, Inc. 08/03/152D 3D TSV
US8975265 371 Substituted imidazo[1,2-a]pyrimidines and —pyridines Bayer Intellectual Property GmbH 08/03/152D 3D TSV
US8975282 8 Substituted pyrazolone compounds and methods of use Sunshine Lake Pharma Co., Ltd.; Calitor Sciences, LLC 08/03/152D 3D TSV
US8975267 51 Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors Nerviano Medical Sciences S.r.l. 08/03/152D 3D TSV
US8962637 76 Bicyclic compounds and their uses as dual c-SRC/JAK inhibitors Debiopharm S.A.; Aurigene Discovery Technologies Ltd. 07/22/152D 3D TSV
US8962651 8 Compounds for the treatment of hepatitis C Bristol-Myers Squibb Company 07/22/152D 3D TSV
US8962674 93 Curcumin derivative Tokyo Institute of Technology; Kyoto University 07/22/152D 3D TSV
US8962837 24 Nitrogen heterocycle derivatives, preparation thereof and application thereof in human therapeutics Pierre Fabre Medicament 07/22/152D 3D TSV
US8962646 38 Peripherally acting opioid compounds Alkermes, Inc. 07/22/152D 3D TSV
US8962659 4 Phenoxyethyl piperidine compounds Eli Lilly and Company 07/22/152D 3D TSV
US8962641 490 Pyrimidine-substituted pyrrolidine derivatives, pharmaceutical compositions and uses thereof Boehringer Ingelheim International GmbH 07/22/152D 3D TSV
US8962630 205 Pyrrolopyrimidine compounds and their uses Novartis AG 07/22/152D 3D TSV
US8962664 3 Selective glycosidase inhibitors and uses thereof Simon Fraser University 07/22/152D 3D TSV
US8962859 12 Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use Amgen Inc. 07/22/152D 3D TSV
US8962648 231 Tricyclic compounds and PBK inhibitors containing the same OncoTherapy Science, Inc. 07/22/152D 3D TSV
US8957084 9 7,8-cyclicmorphinan analogs Purdue Pharma L.P. 07/15/152D 3D TSV
US8957219 12 Acetic acid amide derivative having inhibitory activity on endothelial lipase Shionogi & Co., Ltd. 07/15/152D 3D TSV
US8957103 18 Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment Johannes Gutenberg—Universitat Mainz 07/15/152D 3D TSV
US8962608 1192 Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors Merck Sharp & Dohme Corp. 07/15/152D 3D TSV
US8962616 41 Heterocyclic substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Pfizer Inc. 07/15/152D 3D TSV
US8957093 262 N-biphenylmethylindole modulators of PPARG The Scripps Research Institute 07/15/152D 3D TSV
US8962609 129 Pyrimidine compounds as inhibitors of protein kinases IKK epsilon and/or TBK-1, processes for their preparation, and pharmaceutical compositions containing them Domainex Limited 07/15/152D 3D TSV
US8962611 356 Substituted imidazopyridines as HDM2 inhibitors Merck Sharp & Dohme Corp. 07/15/152D 3D TSV
US8962619 36 Substituted imidazopyridinyl-aminopyridine compounds ArQule, Inc. 07/15/152D 3D TSV
US8962612 20 Tetrahydroisoquinoline derivative Astellas Pharma Inc. 07/15/152D 3D TSV
US8957075 28 O-GlcNAc transferase inhibitors and uses thereof President and Fellows of Harvard College 07/10/152D 3D TSV
US8957077 14 Pyrazolopyrimidine PDE 10 inhibitors Merck Sharp & Dohme Corp. 07/10/152D 3D TSV
US8957074 298 Pyrrolopyrimidine compounds as inhibitors of CDK4/6 Novartis AG 07/10/152D 3D TSV
US8957083 31 Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use Amgen Inc. 07/10/152D 3D TSV
US8957068 870 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Novartis AG 07/09/152D 3D TSV
US8957064 185 Fused pyrimidines Bayer Intellectual Property GmbH 07/09/152D 3D TSV
US8957059 66 Modulators of serotonin receptors Janssen Pharmaceutica NV 07/09/152D 3D TSV
US8957073 378 Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors Amgen Inc. 07/09/152D 3D TSV
US8957057 4 Use of azaphilone compounds for the modulation of the activity of a nuclear hormone receptor Food Industry Research and Development Institute 07/09/152D 3D TSV
US8952177 191 1,2,6-substituted benzimidazoles as FLAP modulators Janssen Pharmaceutica NV 06/29/152D 3D TSV
US8952157 407 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research 06/29/152D 3D TSV
US8952036 5 Benzoic acid derivative MDM2 inhibitor for the treatment of cancer Amgen Inc. 06/29/152D 3D TSV
US8952037 98 Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors Amgen Inc. 06/29/152D 3D TSV
US8956589 22 Imaging diagnostic agent and extracorporeal diagnostic agent for incurable neurological diseases Shiga University of Medical Science 06/29/152D 3D TSV
US8952027 12 Inhibitors of syk and JAK protein kinases Portola Pharmaceuticals, Inc. 06/29/152D 3D TSV
US8952025 3 Multifunctional radical quenchers and their uses Arizona Board of Regents, A Body Corporate of the State of Arizona Acting for and on Behalf of Arizona State University 06/29/152D 3D TSV
US8952169 708 N-substituted benzamides and methods of use thereof Xenon Pharmaceuticals Inc.; Genentech, Inc. 06/29/152D 3D TSV
US8952150 30 Prostaglandin transporter inhibitors and uses thereof Albert Einstein College of Medicine of Yeshiva University 06/29/152D 3D TSV
US8952128 168 Somatostatin-dopamine chimeric analogs Ipsen Pharma S.A.S. 06/29/152D 3D TSV
US8969583 55 3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors Allergan, Inc. 06/22/152D 3D TSV
US8952002 3 Aminoheteroaryl compounds and preparation method and use thereof Shanghai Allist Pharmaceuticals, Inc. 06/22/152D 3D TSV
US8969358 54 Buprenorphine analogs Purdue Pharma L.P. 06/22/152D 3D TSV
US8952008 50 Chemical compounds Pfizer Limited 06/22/152D 3D TSV
US8969348 10 Chymase inhibitors Boehringer Ingelheim International GmbH 06/22/152D 3D TSV
US8969336 95 Diamino heterocyclic carboxamide compound Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd. 06/22/152D 3D TSV
US8969578 13 Inhibitors of STAT3 University of Central Florida Research Foundation, Inc. 06/22/152D 3D TSV
US8969376 43 Pyrazolopyrimidine compounds and their use as PDE10 inhibitors Mitsubishi Tanabe Pharma Corporation 06/22/152D 3D TSV
US8969586 18 Substituted bicyclic heteroaryl compounds Bristol-Myers Squibb Company 06/22/152D 3D TSV
US8969568 125 Substituted naphthyridines and their use as medicaments Boehringer Ingelheim Pharma GmbH & Co. KG 06/22/152D 3D TSV
US8969333 6 Therapeutic compositions and methods The Penn State Research Foundation 06/22/152D 3D TSV
US8969394 24 Thiophenecarboxamide derivatives as EP4 receptor ligands Merck Frosst Canada Ltd. 06/22/152D 3D TSV
US8969335 189 Benzonitrile derivatives as kinase inhibitors MERCK PATENT GmbH 06/16/152D 3D TSV
US8940739 190 Compound of a reverse-turn mimetic and a production method and use therefor JW Pharmaceutical Corporation 06/16/152D 3D TSV
US8940893 17 Heteroaromatic compounds as BTK inhibitors Boehringer Ingelheim International GmbH 06/16/152D 3D TSV
US8940748 21 Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 06/16/152D 3D TSV
US8940720 77 Macrocycles as factor XIa inhibitors Bristol-Myers Squibb Company 06/16/152D 3D TSV
US8940771 29 Organic compounds Novartis AG 06/16/152D 3D TSV
US8940744 33 Pyrazolopyrimidine compounds as kinase inhibitors Principia Biopharma Inc. 06/16/152D 3D TSV
US8969341 345 Pyrazolopyrrolidine compounds Novartis AG 06/16/152D 3D TSV
US8969352 164 Substituted 2-azabicycles and their use as orexin receptor modulators Janssen Pharmaceutica NV 06/16/152D 3D TSV
US8969325 333 TRPV1 antagonists AbbVie Inc. 06/16/152D 3D TSV
US8937070 24 Inhibitors of protein kinases Portola Pharmaceuticals, Inc. 06/15/152D 3D TSV
US8937058 38 17-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivative, use thereof, and medicament containing the derivative TBA 06/08/152D 3D TSV
US8937095 12 Anticancer compounds Boehringer Ingelheim International GmbH 06/08/152D 3D TSV
US8937193 50 Apogossypolone derivatives as anticancer agents Sanford-Burnham Medical Research Institute 06/08/152D 3D TSV
US8937092 22 Aryl or N-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands Gruenenthal GmbH 06/08/152D 3D TSV
US8940736 142 Imidazotriazinecarbonitriles useful as kinase inhibitors Bristol-Myers Squibb Company 06/08/152D 3D TSV
US8940719 16 Lithocholic acid analogues that inhibit sialyltransferase Academia Sinica 06/08/152D 3D TSV
US8937084 27 Nitrogen containing morphinan derivatives and the use thereof Purdue Pharma L.P. 06/08/152D 3D TSV
US8937068 220 Pyridopyrazine derivatives and their use Zentaris GmbH 06/08/152D 3D TSV
US8940738 11 Pyrimidone compounds Mitsubishi Tanabe Pharma Corporation 06/08/152D 3D TSV
US8933228 147 Respiratory formulations and compounds for use therein Respivert, Ltd. 06/08/152D 3D TSV
US8933224 248 Triazine derivatives Pfizer Inc. 06/08/152D 3D TSV
US8927738 26 2-arylimidazole derivatives as PDE10A enzyme inhibitors H. Lundbeck A/S 06/01/152D 3D TSV
US8933024 22 Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases Sanofi 06/01/152D 3D TSV
US8933098 4 Dimethyl-benzoic acid compounds Eli Lilly and Company 06/01/152D 3D TSV
US8933221 31 Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Pfizer Inc. 06/01/152D 3D TSV
US8927730 16 Intramolecular hydrogen-bonded nitric oxide synthase inhibitors Northwestern University 06/01/152D 3D TSV
US8933095 29 KAT II inhibitors Pfizer Inc. 06/01/152D 3D TSV
US8927563 4 Kinase inhibitor Respivert Limited; Topivert Pharma Limited 06/01/152D 3D TSV
US8933099 139 Monocyclic pyridine derivative Eisai R&D Management Co., Ltd. 06/01/152D 3D TSV
US8933079 121 Pyridone and pyridazinone derivatives as anti-obesity agents Boehringer Ingelheim International GmbH 06/01/152D 3D TSV
US8927577 27 Quinolinyl glucagon receptor modulators Pfizer Inc. 06/01/152D 3D TSV
US8933040 7 Selective glycosidase inhibitors and uses thereof TBA 06/01/152D 3D TSV
US8933056 55 Soft protease inhibitors and pro-soft forms thereof Trustees of Tufts College 06/01/152D 3D TSV
US8921559 61 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of CCR2 Janssen Pharmaceutica NV 05/26/152D 3D TSV
US8927520 6 Antibacterial compounds Institut Pasteur; Institut Curie 05/26/152D 3D TSV
US8921397 263 Benzofurane-piperidine compounds Hoffmann-La Roche Inc. 05/26/152D 3D TSV
US8921412 16 C-aryl ansa SGLT2 inhibitors Green Cross Corporation 05/26/152D 3D TSV
US8927534 24 Compounds for the inhibition of integrins and use thereof Shire Orphan Therapies GmbH 05/26/152D 3D TSV
US8927539 10 Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure Vitae Pharmaceuticals, Inc. 05/26/152D 3D TSV
US8921424 13 Histone deacetylase inhibitors, process for preparation and uses thereof Zhejiang Hisun Pharmaceutical Co. Ltd.; Central South University 05/26/152D 3D TSV
US8921421 2 Inhibitors of dimethylarginine dimethylaminohydrolase Christian-Albrechts-Universitaet Zu Kiel 05/26/152D 3D TSV
US8921389 217 Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase Fibrogen, Inc. 05/26/152D 3D TSV
US8921410 175 Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes Targacept, Inc. 05/26/152D 3D TSV
US8927507 8 Selective glycosidase inhibitors and uses thereof TBA 05/26/152D 3D TSV
US8927536 14 Tetrahydrothiazepine derivative Daiichi Sankyo Company, Limited 05/26/152D 3D TSV
US8653304 10 2,3-dihydro-1H-indene-2-yl urea derivative and pharmaceutical application of same Toray Industries, Inc. 05/18/152D 3D TSV
US8916594 27 5-membered ring heteroaromatic derivatives having NPY Y5 receptor antagonistic activity Shionogi & Co., Ltd. 05/18/152D 3D TSV
US8921404 9 Azole derivatives in the form of lipase and phospholipase inhibitors Sanofi 05/18/152D 3D TSV
US8921370 20 Bicyclo[3.2.1]octyl amide derivatives and uses of same H. Lundbeck A/S 05/18/152D 3D TSV
US8921373 25 Compounds having TRPV1 antagonistic activity and uses thereof Shionogi & Co., Ltd. 05/18/152D 3D TSV
US8653257 5 Dibenzothiazepine derivatives and uses thereof—424 Astrazeneca AB 05/18/152D 3D TSV
US8921364 56 Modulators of calcium release-activated calcium channel Rhizen Pharmaceuticals SA 05/18/152D 3D TSV
US8916600 20 Phenyl and benzodioxinyl substituted indazoles derivatives Astrazeneca AB; Bayer Pharma Aktiengesellschaft 05/18/152D 3D TSV
US8921368 103 Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases Bristol-Myers Squibb Company 05/18/152D 3D TSV
US8921319 60 Serine protease inhibitors The Medicines Company (Leipzig) GmbH 05/18/152D 3D TSV
US8653100 267 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG 05/18/152D 3D TSV
US8916577 22 Tricyclic derivatives, process for their preparation and their use as kinase inhibitors Nerviano Medical Sciences S.R.L. 05/18/152D 3D TSV
US8912208 4 (4-{4-[5-(benzooxazol-2-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid useful for treating or preventing conditions or disorders associated with DGAT1 activity Novartis AG 05/11/152D 3D TSV
US8916574 6 4-(substituted anilino)-quinazoline derivatives useful as tyrosine kinase inhibitors Qilu Pharmaceutical Co., Ltd. 05/11/152D 3D TSV
US8912219 10 Aryl sulfamide and sulfamate derivatives as RORc modulators Genentech, Inc. 05/11/152D 3D TSV
US8912221 44 Biaryl amide derivatives Hoffmann-La Roche Inc. 05/11/152D 3D TSV
US8912181 115 Bicyclic compound or salt thereof Taiho Pharmaceutical Co., Ltd. 05/11/152D 3D TSV
US8907086 8 Fused bicyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors Merck Sharp & Dohme Corp. 05/11/152D 3D TSV
US8916576 100 Pharmacokinetically improved compounds Surface Logix, Inc. 05/11/152D 3D TSV
US8912224 390 Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals Sanofi 05/11/152D 3D TSV
US8912173 121 Substituted quinolines and their use as medicaments Boehringer Ingelheim International GmbH 05/11/152D 3D TSV
US8916553 45 Sulfonamide compounds useful as CYP17 inhibitors Bristol-Myers Squibb Company 05/11/152D 3D TSV
US8912213 12 Synthesis and use of dual tyrosyl-DNA phosphodiesterase I (TDP1)- topoisomerase I (TOP1) inhibitors Purdue Research Foundation 05/11/152D 3D TSV
US8906943 19 Synthetic compounds and methods to decrease nicotine self-administration TBA 05/11/152D 3D TSV
US8895581 96 1H-imidazo[4,5-c]quinolines Boehringer Ingelheim International GmbH 05/04/152D 3D TSV
US8901140 7 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. 05/04/152D 3D TSV
US8895745 17 Bicyclic heterocyclic compounds as FGFR inhibitors Astex Therapeutics Limited 05/04/152D 3D TSV
US8906911 68 Chemokine receptor antagonists AbbVie Inc. 05/04/152D 3D TSV
US8895592 76 Compounds as cannabinoid receptor ligands AbbVie Inc. 05/04/152D 3D TSV
US8901115 25 Cyclic P1 linkers as factor XIa inhibitors Bristol-Myers Squibb Company 05/04/152D 3D TSV
US8906933 30 Dihydropyrimidin-2(1H)-one compounds as neurokinin-3 receptor antagonists N30 Pharmaceuticals, Inc. 05/04/152D 3D TSV
US8901295 31 Inhibitors of cyclophilins and uses thereof Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Montpellier 1; Universite Paris-EST Creteil val de Marne; Assistance Publique-Hopitaux de Paris; Centre National de la Recherche Scientifique 05/04/152D 3D TSV
US8901087 39 Selective glycosidase inhibitors and uses thereof Merck Sharp & Dohme Corp. 05/04/152D 3D TSV
US8901315 337 Thienopyrazole derivative having PDE7 inhibitory activity Daiichi Sankyo Company, Limited 05/04/152D 3D TSV
US8901310 29 Tricyclic compounds, compositions, and methods Pfizer Inc. 05/04/152D 3D TSV
US8614223 561 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof Acetylon Pharmaceuticals, Inc. 05/03/152D 3D TSV
US8895549 35 Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Bayer Intellectual Property GmbH 04/27/152D 3D TSV
US8889684 10 Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors Boehringer Ingelheim International GmbH 04/27/152D 3D TSV
US8889671 80 Compounds and methods for treating bacterial infections AstraZeneca AB 04/27/152D 3D TSV
US8889672 29 Compounds, formulations, and methods of protein kinase C inhibition The Regents of The University of Michigan; The Penn State Research Foundation 04/27/152D 3D TSV
US8614195 22 Glycoside derivatives and uses thereof Novartis AG 04/27/152D 3D TSV
US8895544 57 Indazoles Pfizer Limited 04/27/152D 3D TSV
US8895245 10 Inhibitors of human EZH2 and methods of use thereof Epizyme, Inc. 04/27/152D 3D TSV
US8889870 111 Kinase inhibitors Allergan, Inc. 04/27/152D 3D TSV
US8894989 59 PARP inhibitor compounds, compositions and methods of use Eisai Inc. 04/27/152D 3D TSV
US8889708 42 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C Boehringer Ingelheim International GmbH 04/27/152D 3D TSV
US8889696 65 Substituted pyrido[2,3-d]pyrimidin-7(8H)-ones and therapeutic uses thereof Temple University—Of The Commonwealth System Of Higher Education 04/27/152D 3D TSV
US8889724 7 Tetrazole compounds for reducing uric acid Wellstat Therapeutics Corporation 04/27/152D 3D TSV
US8877733 2 1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment Gilead Sciences, Inc. 04/20/152D 3D TSV
US8884017 21 2-heteroarylcarboxylic acid amides Bayer Intellectual Property GmbH 04/20/152D 3D TSV
US8883759 20 Anti-tumor effect potentiator Taiho Pharmaceutical Co., Ltd. 04/20/152D 3D TSV
US8883784 15 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases AbbVie Inc. 04/20/152D 3D TSV
US8883771 150 Bivalent inhibitors of IAP proteins and therapeutic methods using the same The Regents of the University of Michigan 04/20/152D 3D TSV
US8614213 83 Cyclohexyl amide derivatives and their use as CRF-1 receptor antagonists Novartis AG 04/20/152D 3D TSV
US8883797 12 Metalloenzyme inhibitor compounds Viamet Pharmaceuticals, Inc. 04/20/152D 3D TSV
US8889668 31 Oxadiazole diaryl compounds Merck Serono SA 04/20/152D 3D TSV
US8877741 485 Pyrrolidine derivatives, pharmaceutical compositions and uses thereof Boehringer Ingelheim International GmbH 04/20/152D 3D TSV
US8614220 15 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors Nerviano Medical Sciences S.r.l. 04/20/152D 3D TSV
US8883846 5 Synthesis of bicyclic compounds and method for their use as therapeutic agents UVic Industry Partnerships Inc. 04/20/152D 3D TSV
US8877798 71 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders Neurovance, Inc. 04/13/152D 3D TSV
US8877944 96 3-oxo-2,3-dihydro-1H-isoindole-4-carboxamides as PARP inhibitors Nerviano Medical Sciences S.R.L. 04/13/152D 3D TSV
US8877778 285 Benzofurane compounds Hoffmann-La Roche Inc. 04/13/152D 3D TSV
US8877967 42 Compositions and methods for inhibition of cathepsins OXiGENE, Inc.; Baylor University 04/13/152D 3D TSV
US8871738 76 Fused bicyclic oxazolidinone CETP inhibitor Merck Sharp & Dohme Corp. 04/13/152D 3D TSV
US8877795 33 Identification of stabilizers of multimeric proteins The Board of Trustees of the Leland Stanford Junior University 04/13/152D 3D TSV
US8877791 8 Inhibitors of pyruvate kinase and methods of treating disease Beth Israel Deaconess Medical Center, Inc. 04/13/152D 3D TSV
US8871728 49 Non-peptide macrocyclic histone deacetylese (HDAC) inhibitors and methods of making and using thereof Georgia Tech Research Corporation 04/13/152D 3D TSV
US8877757 7 Pyrazine derivatives and use as PI3K inhibitors Merck Serono SA 04/13/152D 3D TSV
US8877775 37 Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C Boehringer Ingelheim International GmbH 04/13/152D 3D TSV
US8877786 7 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors Novartis AG 04/13/152D 3D TSV
US8871778 44 Substituted pyrimidine compounds and their use as SYK inhibitors Genosco; Oscotec, Inc. 04/13/152D 3D TSV
US8865911 180 Compounds and their use as BACE inhibitors Astrazeneca AB 04/06/152D 3D TSV
US8865655 4 Depsipeptides and their therapeutic use Karus Therapeutics Limited 04/06/152D 3D TSV
US8871934 680 Fluorene compound and pharmaceutical use thereof Japan Tobacco Inc. 04/06/152D 3D TSV
US8865706 30 Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Pfizer Inc. 04/06/152D 3D TSV
US8871790 475 Heterocyclic modulators of lipid synthesis 3-V Biosciences, Inc. 04/06/152D 3D TSV
US8865662 5 Macrolides and their use Basilea Pharmaceutica AG 04/06/152D 3D TSV
US8865698 105 Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds Array BioPharma Inc. 04/06/152D 3D TSV
US8865714 35 Piperazine compound capable of inhibiting prostaglandin D synthase Taiho Pharmaceutical Co., Ltd. 04/06/152D 3D TSV
US8865701 11 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer'S disease Merck Sharp & Dohme Corp. 04/06/152D 3D TSV
US8871783 26 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (cyano-methyl)-amides inhibitors of cathepsin C Boehringer Ingelheim International GmBh 04/06/152D 3D TSV
US8865726 144 Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors Array BioPharma Inc. 04/06/152D 3D TSV
US8865686 8 Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitors The United States of America, as Represented by the Secretary, Dept. of Health and Human Services 04/06/152D 3D TSV
US8859534 106 2-carboxamide-7-piperazinyl-benzofuran derivatives Acturum Life Science AB 03/16/152D 3D TSV
US8853224 62 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases Industrial Research Limited; Albert Einstein College of Medicine of Yeshiva University 03/16/152D 3D TSV
US8859596 128 Compounds as cannabinoid receptor ligands AbbVie Inc. 03/16/152D 3D TSV
US8859586 50 Cyclohexyl isoquinolinone compounds Novartis AG 03/16/152D 3D TSV
US8853215 17 Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes Takeda Pharmaceutical Company Limited 03/16/152D 3D TSV
US8853203 366 Diazepinone derivatives Novartis AG 03/16/152D 3D TSV
US8853227 9 Methotrexate adjuvants to reduce toxicity and methods for using the same Tosk, Incorporated 03/16/152D 3D TSV
US8865750 10 Small molecule inhibitors of RGS proteins The Regents of The University of Michigan; The University of Bath 03/16/152D 3D TSV
US8853212 17 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes Merck Sharp & Dohme Corp 03/16/152D 3D TSV
US8853193 170 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions Boehringer Ingelheim International GmbH 03/16/152D 3D TSV
US8853206 11 Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments Sanofi 03/16/152D 3D TSV
US8853226 26 Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors High Point Pharmaceuticals, LLC 03/16/152D 3D TSV
US8853258 197 C-linked hydroxamic acid derivatives useful as antibacterial agents Pfizer Inc. 03/09/152D 3D TSV
US8853228 67 Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase University of Connecticut 03/09/152D 3D TSV
US8853207 12 Heterocyclic pyrazole compounds, method for preparing the same and use thereof Development Center for Biotechnology 03/09/152D 3D TSV
US8846601 142 Melanocortin receptor-specific peptides Palatin Technologies, Inc. 03/09/152D 3D TSV
US8853242 18 Nitrogenous-ring acylguanidine derivative Astellas Pharma Inc. 03/09/152D 3D TSV
US8846658 184 Oxazine derivatives and their use in the treatment of neurological disorders Novartis AG 03/09/152D 3D TSV
US8846698 511 Pyrrolo[2,3-d]pyrimidine tropomysin-related kinase inhibitors Pfizer Limited 03/09/152D 3D TSV
US8846000 35 Radiolabeled PDE10 inhibitors Merck Sharp & Dohme Corp. 03/09/152D 3D TSV
US8846657 356 Substituted imidazopyridines as HDM2 inhibitors Merck Sharp & Dohme Corp. 03/09/152D 3D TSV
US8846656 146 Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators Novartis AG 03/09/152D 3D TSV
US8846654 11 Therapeutic applications in the cardiovascular field of quinazolinedione derivatives Sanofi 03/09/152D 3D TSV
US8846673 38 Azaindazoles as kinase inhibitors and use thereof Bristol-Myers Squibb Company 03/03/152D 3D TSV
US8846730 132 Compounds as cannabinoid receptor ligands AbbVie Inc. 03/03/152D 3D TSV
US8846711 28 Heterocyclic acrylamides and their use as pharmaceuticals Fab Pharma S.A.S. 03/03/152D 3D TSV
US8846719 372 Isoxazolo-pyridine derivatives Roche Palo Alto LLC 03/03/152D 3D TSV
US8846741 9 N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG 03/03/152D 3D TSV
US8846696 60 Purine derivatives Cyclacel Limited; Cancer Research Technology Limited 03/03/152D 3D TSV
US8846746 520 Pyrazole compound and pharmaceutical use thereof Japan Tobacco Inc. 03/03/152D 3D TSV
US8846699 346 Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof Hanmi Pharm. Co., Ltd. 03/03/152D 3D TSV
US8846660 29 Seven-membered ring compound and pharmaceutical use therefor Daiichi Sankyo Company, Ltd. 03/03/152D 3D TSV
US8846689 212 Substituted pyrimidines for the treatment of diseases such as cancer Boehringer Ingelheim International GmbH 03/03/152D 3D TSV
US8846929 836 Substituted-quinoxaline-type piperidine compounds and the uses thereof Purdue Pharma L.P.; Shionogi & Co., Ltd. 03/03/152D 3D TSV
US8835436 169 Arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same Green Cross Corporation 02/23/152D 3D TSV
US8841450 2 Compounds useful as inhibitors of ATR kinase Vertex Pharmaceuticals Incorporated 02/23/152D 3D TSV
US8846917 1 Compounds useful as inhibitors of ATR kinase Vertex Pharmaceuticals Incorporated 02/23/152D 3D TSV
US8835444 36 Cyclohexyl amide derivatives as CRF receptor antagonists Novartis AG 02/23/152D 3D TSV
US8835445 82 Dihydrofolate reductase inhibitors Trius Therapeutics, Inc. 02/23/152D 3D TSV
US8841312 749 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors Amgen Inc. 02/23/152D 3D TSV
US8841453 36 Hybrid cholinesterase inhibitors Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego 02/23/152D 3D TSV
USRE45173 173 Inhibitors of CYP 17 Novartis AG 02/23/152D 3D TSV
US8841288 10 Quinolin-4 (1H)-one derivatives as inhibitors of phosphatidylinositol 3-kinases Universtà Degli Studi di Torino; Università Degli Studi del Piemonte Orientale “Amedeo Avogadro” 02/23/152D 3D TSV
US8841455 165 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors Array BioPharma Inc. 02/23/152D 3D TSV
US8835464 53 Triazole compounds that modulate HSP90 activity Synta Pharmaceuticals Corp. 02/23/152D 3D TSV
US8835472 664 Compounds, pharmaceutical compositions and uses thereof Boehringer Ingelheim International GmbH 02/16/152D 3D TSV
US8828983 13 Macrocycles as factor XIa inhibitors Bristol-Myers Squibb Company 02/16/152D 3D TSV
US8835470 25 Mandelamide heterocyclic compounds Bristol-Myers Squibb Company 02/16/152D 3D TSV
US8829193 162 PIM kinase inhibitors and methods of their use Novartis AG 02/16/152D 3D TSV
US8835659 7 Polysubstituted benzofurans and medicinal applications thereof Ikerchem, S.L.; Universidad del Pais Vasco 02/16/152D 3D TSV
US8829010 57 Pyrazolo[3,4-d]pyrimidine compounds and their use as PDE2 inhibitors and/or CYP3A4 inhibitors Pfizer Inc. 02/16/152D 3D TSV
US8835465 3 Pyrazolylaminopyridine derivatives useful as kinase inhibitors AstraZeneca AB 02/16/152D 3D TSV
US8829009 6 Substituted 2-amino-3-(sulfonyl)pyrazolo[1,5-a]pyrimidines - serotonin 5-HT6 receptor antagonists, method for use thereof TBA 02/16/152D 3D TSV
US8829000 22 Substituted imidazo[1,5-A]quinoxalines as phosphodiesterase 9 inhibitors ASKA Pharmaceutical Co., Ltd. 02/16/152D 3D TSV
US8829190 28 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases Leo Pharma A/S 02/16/152D 3D TSV
US8822479 7 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines Boehringer Ingelheim International GmbH 02/02/152D 3D TSV
US8829199 333 Aminopyrazole derivative Chugai Seiyaku Kabushiki Kaisha; F. Hoffmann-La Roche AG 02/02/152D 3D TSV
US8822505 100 Azetidine derivatives Genentech, Inc. 02/02/152D 3D TSV
US8829200 30 Benzimidazole inhibitors of leukotriene production Boehringer Ingelheim International GmbH 02/02/152D 3D TSV
US8822460 15 Fused cyclopentyl antagonists of CCR2 Janssen Pharmaceutica NV 02/02/152D 3D TSV
US8822494 47 Heteroaromatic compounds and their use as dopamine D1 ligands Pfizer Inc. 02/02/152D 3D TSV
US8822447 155 Indazole compounds useful as ketohexokinase inhibitors Janssen Pharmaceutica NV 02/02/152D 3D TSV
US8822457 4 Inhibitors of bruton's tyrosine kinase Roche Palo Alto LLC 02/02/152D 3D TSV
US8822448 100 Pyrazoloquinoline compound Astellas Pharma Inc. 02/02/152D 3D TSV
US8822510 15 Substituted 3-phenyl-1,2,4-Oxadiazole compounds Bristol-Myers Squibb Company 02/02/152D 3D TSV
US8822458 61 Substituted oxazolidinones and their use in the field of blood coagulation Bayer Intellectual Property GmbH 02/02/152D 3D TSV
US8822500 55 Tyrosine kinase inhibitors Chembridge Corporation 02/02/152D 3D TSV
US8815881 20 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds Hoffmann-La Roche Inc.; Siena Biotech S.p.A. 01/26/152D 3D TSV
US8815845 10 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties The Regents of the University of Michigan 01/26/152D 3D TSV
US8815927 11 Bivalent diazo bicyclic Smac mimetics and the uses thereof The Regents of the University of Michigan 01/26/152D 3D TSV
US8815852 34 Carbamoyloxy arylalkan arylpiperazine analgesics SK Biopharmaceuticals Co., Ltd. 01/26/152D 3D TSV
US8815840 94 Carbazole and carboline kinase inhibitors Bristol-Myers Squibb Company 01/26/152D 3D TSV
US8815918 14 Imidazo [2, 1-B] [1, 3, 4] thiadiazole derivatives Centro Nacional de Investigaciones Oncologicas (CNIO) 01/26/152D 3D TSV
US8815901 52 Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors Novartis AG 01/26/152D 3D TSV
US8822534 22 Substituted aminopropionic derivatives as neprilysin inhibitors Novartis AG 01/26/152D 3D TSV
US8815854 24 Substituted imidazopyridinyl compounds ArQule, Inc. 01/26/152D 3D TSV
US8815926 334 Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases Novartis AG 01/26/152D 3D TSV
US8815891 114 Tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same Je Il Pharmaceutical Co., Ltd. 01/26/152D 3D TSV
US8815934 54 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations Wyeth LLC 01/19/152D 3D TSV
US8802674 212 Aminopyrimidine derivatives as LRRK2 modulators Genentech, Inc. 01/19/152D 3D TSV
US8816088 96 Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity Theravance Respiratory Company, LLC 01/19/152D 3D TSV
US8802679 44 Glycine compound Astellas Pharma Inc. 01/19/152D 3D TSV
US8802673 421 Heterocyclic amine derivatives Hoffmann-La Roche Inc 01/19/152D 3D TSV
US8815951 300 Inhibitors of epoxide hydrolases for the treatment of inflammation The Regents of the University of California 01/19/152D 3D TSV
US8802663 45 Pyrazole oxadiazole derivatives as S1P1 agonists Merck Serono SA 01/19/152D 3D TSV
US8802712 80 Pyrazoloquinolines Merck Patent GmbH 01/19/152D 3D TSV
US8802672 27 Pyrimidinyl-piperazines useful as D3/D2 receptor ligands Richter Gedeon Nyrt. 01/19/152D 3D TSV
US8802665 48 Pyrrolidine derivatives Genentech, Inc. 01/19/152D 3D TSV
US8802686 63 Sulfone-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as a medicine Bayer Intellectual Property GmbH 01/19/152D 3D TSV
US8802711 155 TRPV1 antagonists AbbVie Inc. 01/19/152D 3D TSV
US8796280 46 2,3-disubstituted pyrazinesulfonamides as CRTH2 inhibitors Merck Serono, S.A. 01/12/152D 3D TSV
US8796284 21 4-aminopyrimidine derivatives and their as as adenosine A2a receptor antagonists Palobiofarma, S.L. 01/12/152D 3D TSV
US8796296 33 Aminopyrimidine derivatives as LRRK2 modulators Genentech, Inc. 01/12/152D 3D TSV
US8802695 41 Apoptosis signal-regulating kinase 1 inhibitors Takeda Pharmaceutical Company Limited 01/12/152D 3D TSV
US8796244 586 Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases Astex Therapeutics Ltd 01/12/152D 3D TSV
US8802724 5 Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans Purdue Research Foundation 01/12/152D 3D TSV
US8796293 9 Purine and deazapurine derivatives as pharmaceutical compounds Astex Therapeutics Limited; The Institute of Cancer Research: Royal Cancer Hospital; Cancer Research Technology Limited 01/12/152D 3D TSV
US8796295 30 Substituted benzamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same Vanderbilt University 01/12/152D 3D TSV
US8802861 17 Thiazole derivatives and use thereof Merck Serono SA 01/12/152D 3D TSV
US8802721 9 Thiophene compounds for inflammation and immune-related uses Synta Pharmaceuticals Corp. 01/12/152D 3D TSV
US8802864 12 Triazolones as fatty acid synthase inhibitors GlaxoSmithKline LLC 01/12/152D 3D TSV
US8796297 46 4-substituted-2-amino-pyrimidine derivatives AbbVie Inc. 12/22/142D 3D TSV
US8796310 83 Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitors Merck Sharp & Dohme Corp. 12/22/142D 3D TSV
US8791130 46 Aminopyrimidine derivatives as LRRK2 modulators Genentech, Inc. 12/22/142D 3D TSV
US8791100 79 Aryl benzylamine compounds Novartis AG 12/22/142D 3D TSV
US8796457 1 Compound useful for the treatment of degenerative and inflammatory diseases Galapagos NV 12/22/142D 3D TSV
US8796330 80 Inhibitors of histone deacetylase and prodrugs thereof Methylgene Inc. 12/22/142D 3D TSV
US8791118 38 Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitors Aeterna Zentaris GmbH 12/22/142D 3D TSV
US8791123 504 Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors Array Biopharma, Inc. 12/22/142D 3D TSV
US8796328 44 TRPV1 antagonists TBA 12/22/142D 3D TSV
US8796304 19 Tricyclic imidazole compounds as PDE10 inhibitors H. Lundbeck A/S 12/22/142D 3D TSV
US8785467 20 Alkoxy pyrimidine PDE10 inhibitors Merck Sharp & Dohme Corp. 12/16/142D 3D TSV
US8785489 97 Heteroaryl substituted indole compounds useful as MMP-13 inhibitors Boehringer Ingelheim International GmbH 12/16/142D 3D TSV
US8785477 9 Hexahydropyrrolo[3,4-b]pyrrole derivatives, preparation methods and pharmaceutical uses thereof Shanghai Sun-Sail Pharmaceutical Science & Technology Co., Ltd. 12/16/142D 3D TSV
US8791131 292 Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions Pfizer Inc. 12/16/142D 3D TSV
US8791272 215 Pyrazole compounds as CRTH2 antagonists Boehringer Ingelheim International GmbH 12/16/142D 3D TSV
US8785464 81 Pyrimidine derivatives that inhibit FAK/PTK2 Boehringer Ingelheim International GmbH 12/16/142D 3D TSV
US8785459 386 Quinazoline compounds as kinase inhibitors Development Center for Biotechnology 12/16/142D 3D TSV
US8791257 60 Substituted pyrrolotriazines as protein kinase inhibitors Bristol-Myers Squibb Company 12/16/142D 3D TSV
US8791268 22 Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions Gruenenthal GmbH 12/16/142D 3D TSV
US8778932 5 Dihydro-oxazolobenzodiazepinone compounds, a process for there preparation and pharmaceutical compositions containing them Les Laboratoires Servier; Egis Gyogyszergyar Nyrt 12/15/142D 3D TSV
US8785634 9 Spiropiperidine prolylcarboxypeptidase inhibitors Merck Sharp & Dohme Corp 12/15/142D 3D TSV
US8785499 8 Targeting NAD biosynthesis in bacterial pathogens University of Maryland, Baltimore; The Board of Regents of the University of Texas System; Sanford-Burnham Medical Research Institute 12/15/142D 3D TSV
US8779142 157 Azabicyclo compound and salt thereof Taiho Pharmaceutical Co., Ltd. 12/08/142D 3D TSV
US8772304 33 Benzimidazole inhibitors of leukotriene production Boehringer Ingelheim International GmbH 12/08/142D 3D TSV
US8772285 2 Benzothiazoles having histamine H3 receptor activity High Point Pharmaceuticals, LLC 12/08/142D 3D TSV
US8778970 55 Benzyl piperidine compound Dainippon Sumitomo Pharma Co., Ltd 12/08/142D 3D TSV
US8778957 21 CGRP receptor antagonists Merck Sharp & Dohme Corp. 12/08/142D 3D TSV
US8778951 352 Heteroaryl compounds and their uses Novartis AG 12/08/142D 3D TSV
US8772283 128 Imidazo-oxazine compound or salt thereof Taiho Pharmaceutical Co., Ltd. 12/08/142D 3D TSV
US8778412 32 Methods for increasing the stabilization of hypoxia inducible factor-1 alpha Aerpio Therapeutics Inc. 12/08/142D 3D TSV
US8772288 36 Substituted spiro[cycloalkyl-1,3′-indo]-2′(1′H)-one derivatives and their use as P38 mitogen-activated kinase inhibitors Almirall, S.A. 12/08/142D 3D TSV
US8772297 20 TGF-β signal transduction inhibitor Kyoto University 12/08/142D 3D TSV
US8772282 6 Tetrahydropyrrolothiazine compounds Eli Lilly and Company 12/08/142D 3D TSV
US8785638 71 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors Katholieke Universiteit Leuven 12/08/142D 3D TSV
US8772495 1 5-lipoxygenase-activating protein inhibitor Panmira Pharmaceuticals, LLC 11/24/142D 3D TSV
US8765733 21 Amine substituted methanesulfonamide derivatives as vanilloid receptor ligands Gruenenthal GmbH 11/24/142D 3D TSV
US8772481 21 Aza- and diaza-phthalazine compounds as P38 map kinase modulators and methods of use thereof Amgen Inc. 11/24/142D 3D TSV
US8772511 7 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists Bayer Intellectual Property GmbH 11/24/142D 3D TSV
US8765744 129 Azaspirohexanones Boehringer Ingelheim International GmbH 11/24/142D 3D TSV
US8772478 21 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics Galderma Research & Development 11/24/142D 3D TSV
US8772480 690 Inhibitors of PI3 kinase and/or mTOR Amgen Inc. 11/24/142D 3D TSV
US8772508 17 Inhibitors of glutaminyl cyclase Probiodrug AG 11/24/142D 3D TSV
US8765727 95 Macrocyclic compounds and their use as kinase inhibitors Incyte Corporation 11/24/142D 3D TSV
US8772510 65 PDE10 modulators Hoffmann-La Roche Inc. 11/24/142D 3D TSV
US8772316 84 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A) Allergan, Inc.; Exonhit Therapeutics SA 11/24/142D 3D TSV
US8772305 292 Substituted pyridinyl-pyrimidines and their use as medicaments Boehringer Ingelheim International GmbH 11/24/142D 3D TSV
US8765972 19 3-oxo-2,3-dihydro-1H-isoindole-4-carboxamides with selective PARP-1 inhibition Nerviano Medical Sciences S.r.l. 11/18/142D 3D TSV
US8759537 85 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents Boehringer Ingelheim International GmbH 11/18/142D 3D TSV
US8759366 48 Aminopyrimidines as SYK inhibitors Merck Sharp & Dohme Corp.; Merck Canada Inc. 11/18/142D 3D TSV
US8759341 15 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof Bayer Intellectual Property GmbH 11/18/142D 3D TSV
US8765747 21 Fused 2-aminothiazole compounds Dana-Farber Cancer Institute, Inc. 11/18/142D 3D TSV
US8765940 162 Heterocyclic compounds and their uses Amgen Inc. 11/18/142D 3D TSV
US8759338 57 Heterocyclic kinase inhibitors Novartis AG 11/18/142D 3D TSV
US8759365 23 Organic compounds Novartis AG 11/18/142D 3D TSV
US8765750 27 Piperazine compound having a PGDS inhibitory effect Taiho Pharmaceutical Co., Ltd. 11/18/142D 3D TSV
US8759386 59 Pyrazole compounds as CRTH2 antagonists Boehringer Ingelheim International GmbH 11/18/142D 3D TSV
US8759532 266 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors Amgen Inc. 11/18/142D 3D TSV
US8765820 21 Tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and/or LSD2 Universita Degli Studi di Roma “La Sapienza”; Fondazione IEO; Universita Degli Studi di Pavia; Universita Degli Studi di Milano 11/18/142D 3D TSV
US8754075 87 1,3-oxazines as BACE1 and/or BACE2 inhibitors Hoffmann-La Roche Inc. 11/11/142D 3D TSV
US8748418 53 1,4-oxazepines as BACE1 and/or BACE2 inhibitors Hoffmann-La Roche Inc. 11/11/142D 3D TSV
US8748608 39 4-phenylpiperazine derivatives with functionalized linkers as dopamine D3 receptor selective ligands and methods of use The United States of America as Represented by the Secretary of the Department of Health and Human Services; The University of North Texas Health Science Center at Fort Worth 11/11/142D 3D TSV
US8748451 35 HDAC inhibitors and therapeutic methods of using same The Board of Trustees of The University of Illinois 11/11/142D 3D TSV
US8754089 32 Heterocyclic compounds and their uses Amgen Inc. 11/11/142D 3D TSV
US8754106 9 Macrocyclic inhibitors of hepatitis C virus Janssen R&D Ireland; Medivir AB 11/11/142D 3D TSV
US8754105 6 Macrocyclic inhibitors of hepatitis C virus Medivir AB; Janssen R&D Ireland 11/11/142D 3D TSV
US8754227 15 Metalloenzyme inhibitor compounds Viamet Pharmaceuticals, Inc. 11/11/142D 3D TSV
US8754099 5 Oxadiazole beta carboline derivatives as antidiabetic compounds Merck Sharp & Dohme Corp 11/11/142D 3D TSV
US8754113 39 Oxadiazole derivative having endothelial lipase inhibitory activity Shionogi & Co., Ltd. 11/11/142D 3D TSV
US8754233 151 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents Dermira (Canada), Inc. 11/11/142D 3D TSV
US8748458 41 Scriptaid isosteres and their use in therapy Karus Therapeutics Limited 11/11/142D 3D TSV
US8741907 16 Alkyl-substituted pyrazolopyrimidines Boehringer Ingelheim International GmbH 11/05/142D 3D TSV
US8741944 37 Anti-infective agents against intracellular pathogens The Ohio State University Research Foundation 11/05/142D 3D TSV
US8741915 24 Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors N30 Pharmaceuticals, Inc. 11/05/142D 3D TSV
US8742106 172 Disubstituted heteroaryl-fused pyridines Novartis AG 11/05/142D 3D TSV
US8748618 36 Inhibitors of inv(16) leukemia University of Virginia Patent Foundation 11/05/142D 3D TSV
US8741926 10 Macrocyclic inhibitors of hepatitis C virus Janssen R&D Ireland; Medivir AB 11/05/142D 3D TSV
US8741923 19 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis Merck Serono SA 11/05/142D 3D TSV
US8748626 8 Oxazole and thiazole compounds as KSP inhibitors Novartis AG 11/05/142D 3D TSV
US8748624 138 Picolinamido-propanoic acid derivatives useful as glucagon receptor antagonists Janssen Pharmaceutica NV 11/05/142D 3D TSV
US8748435 37 Pyrazolo pyrimidine derivatives Novartis AG 11/05/142D 3D TSV
US8742113 21 Furanone derivative SBI Biotech Co., Ltd.; Carna Biosciences, Inc. 11/04/142D 3D TSV
US8742110 170 Spiroxazolidinone compounds Merck Sharp & Dohme Corp. 11/04/142D 3D TSV
US8729113 97 4,5-dihydro-oxazol-2yl derivatives Hoffmann-La Roche Inc. 10/28/142D 3D TSV
US8742134 8 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof Theron Pharmaceuticals, Inc. 10/28/142D 3D TSV
US8735386 429 Aminopyrazoloquinazolines Boehringer Ingelheim International GmbH 10/28/142D 3D TSV
US8735593 10 Aminopyridines useful as inhibitors of protein kinases Vertex Pharmaceuticals Incorporated 10/28/142D 3D TSV
US8742115 35 Co-crystals and salts of CCR3-inhibitors Boehringer Ingelheim International GmbH 10/28/142D 3D TSV
US8722692 731 Compounds and compositions as Syk kinase inhibitors TBA 10/28/142D 3D TSV
US8742138 35 Compounds as hypoxia mimetics, and compositions and uses thereof Betta Pharmaceuticals Co., Ltd. 10/28/142D 3D TSV
US8729074 47 Inhibitors of PI3 kinase Amgen Inc. 10/28/142D 3D TSV
US8729078 50 Inhibitors of bruton's tyrosine kinase Hoffmann-La Roche Inc. 10/28/142D 3D TSV
US8735395 13 Protease inhibitors Medivir AB 10/28/142D 3D TSV
US8742158 44 Protease inhibitors TaiMed Biologies, Inc. 10/28/142D 3D TSV
US8729061 248 Pyrrolidine derivatives Hoffmann-La Roche Inc. 10/28/142D 3D TSV
US8722877 5 7-deazapurine modulators of histone methyltransferase, and methods of use thereof Epizyme, Inc. 10/20/142D 3D TSV
US8722683 231 Benzodioxole piperazine compounds Hoffmann LA-Roche Inc. 10/20/142D 3D TSV
US8716478 12 Boron-containing small molecules Anacor Pharmaceuticals, Inc. 10/20/142D 3D TSV
US8729273 31 Compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same LG Life Sciences Ltd. 10/20/142D 3D TSV
US8722718 2 Inhibitors of C-FMS kinase Janssen Pharmaceutica NV 10/20/142D 3D TSV
US8716296 11 Inhibitors of protein kinases Ingenium Pharmaceuticals GmbH 10/20/142D 3D TSV
US8722709 57 Mineralocorticoid receptor antagonists Boehringer Ingelheim International GmbH 10/20/142D 3D TSV
US8716285 65 N-hydroxy-benzamids for the treatment of cancer Hoffmann-La Roche Inc. 10/20/142D 3D TSV
US8716287 65 Pharmaceutical compounds Sentinel Oncology Limited 10/20/142D 3D TSV
US8722896 588 Prokineticin receptor antagonists and uses thereof The Regents of the University of California 10/20/142D 3D TSV
US8722895 34 Prolyl hydroxylase inhibitors and method of use Akebia Therapeutics, Inc. 10/20/142D 3D TSV
US8722721 18 SEC-hydroxycyclohexyl derivatives Hoffmann-La Roche Inc. 10/20/142D 3D TSV
US8722890 54 Thieno[3,2-C]pyridine kinase inhibitors with improved CYP safety profile AbbVie Inc. 10/20/142D 3D TSV
US8710076 8 2,5-disubstituted piperidine orexin receptor antagonists Merck Sharp & Dohme Corp. 10/14/142D 3D TSV
US8703785 9 2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having BACE1-inhibiting activity Shionogi & Co., Ltd. 10/14/142D 3D TSV
US8703807 12 Azaspirodecanone compounds Hoffmann-La Roche Inc. 10/14/142D 3D TSV
US8703947 11 Compounds for treatment of Alzheimer's disease Purdue Research Foundation 10/14/142D 3D TSV
US8703720 17 Galactoside inhibitors of galectins Galecto Biotech AB 10/14/142D 3D TSV
US8710232 17 Imidazole derivatives used as TAFIa inhibitors Sanofi-Aventis Deutschland GmbH 10/14/142D 3D TSV
US8703768 340 Nitrogen containing heteroaryl compounds Hoffmann-La Roche Inc. 10/14/142D 3D TSV
US8703761 15 Organic compounds Novartis AG 10/14/142D 3D TSV
US8703771 45 Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor Harbin Gloria Pharmaceuticals Co., Ltd. 10/14/142D 3D TSV
US8703770 2 Pyridazine carboxamide orexin receptor antagonists Merck Sharp & Dohme Corp. 10/14/142D 3D TSV
US8703811 138 Small molecule inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase Genzyme Corporation; Massachusetts Institute of Technology; President and Fellows of Harvard College 10/14/142D 3D TSV
US8703767 18 Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors University of Utah Research Foundation 10/14/142D 3D TSV
US8716482 17 Substituted aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes Merck Sharp & Dohme Corp. 10/14/142D 3D TSV
US8697869 57 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carbazole derivatives and their use as prostaglandin D2 receptor modulators Actelion Pharmaceuticals Ltd. 10/06/142D 3D TSV
US8697868 10 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions Boehringer Ingelheim International GmbH 10/06/142D 3D TSV
US8697708 16 Azabenzothiazole compounds, compositions and methods of use F. Hoffmann-La Roche AG 10/06/142D 3D TSV
US8697716 17 Method of inhibiting C-KIT kinase Janssen Pharmaceutica NV 10/06/142D 3D TSV
US8691753 866 Pseudodipeptides as MMP inhibitors Commissariat A l'Energie Atomique et Aux Energies Alternatives 10/06/142D 3D TSV
US8697911 172 Rho kinase inhibitors Boehringer Ingelheim International GmbH 10/06/142D 3D TSV
US8697715 42 Serine/threonine kinase inhibitors Array BioPharma, Inc.; Genentech, Inc. 10/06/142D 3D TSV
US8697696 11 Triazole compounds II Roche Palo Alto LLC 10/06/142D 3D TSV
US8691852 26 Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors Amirall, S.A. 09/30/142D 3D TSV
US8691827 9 Amino tetrahydro-pyridopyrimidine PDE10 inhibitors Merck Sharp & Dohme Corp. 09/30/142D 3D TSV
US8691986 34 Azetidine and piperidine compounds useful as PDE10 inhibitors Amgen Inc. 09/30/142D 3D TSV
US8691856 2 Glucagon receptor antagonists, preparation and therapeutic uses Eli Lilly and Company 09/30/142D 3D TSV
US8691840 5 N-biarylamides Bayer Intellectual Property GmbH 09/30/142D 3D TSV
US8691993 13 Piperidinyl naphthylacetic acids Hoffmann-La Roche Inc. 09/30/142D 3D TSV
US8685958 20 Therapeutic agents AstraZeneca AB 09/30/142D 3D TSV
US8691829 4 Treatment of liver disorders with PI3K inhibitors Gilead Calistoga LLC 09/30/142D 3D TSV
US8691832 20 Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors Merck Sharp & Dohme Corp. 09/30/142D 3D TSV
US8680119 4 Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto Arena Pharmaceuticals, Inc. 09/16/142D 3D TSV
US8680275 351 Fused heterocyclic compounds as orexin receptor modulators Janssen Pharmaceutica NV 09/16/142D 3D TSV
US8686042 2 GSK-3 inhibitors Neuropharma, S.A. 09/16/142D 3D TSV
US8685992 120 Histone deacetylase inhibitors based simultaneously on trisubstituted 1H-pyrroles and aromatic and heteroaromatic spacers Universidad del País Vasco; Ikerschem, S.L. 09/16/142D 3D TSV
US8680120 31 Indole derivative or pharmaceutically acceptable salt thereof Kissei Pharmaceutical Co., Ltd. 09/16/142D 3D TSV
US8685986 12 Medical composition for treatment or prophylaxis of glaucoma Ube Industries, Ltd. 09/16/142D 3D TSV
US8686018 9 Pharmaceutical composition Eisai R&D Management Co., Ltd. 09/16/142D 3D TSV
US8680116 9 Quinolinone PDE2 inhibitors Merck Sharp & Dohme Corp. 09/16/142D 3D TSV
US8680132 72 Spiro-oxindole MDM2 antagonists The Regents of the University of Michigan; Ascenta Licensing Corporation; Sanofi 09/16/142D 3D TSV
US8673938 23 Chemical compounds AstraZeneca AB 09/08/142D 3D TSV
US8673906 102 Chromenone derivatives AstraZeneca AB 09/08/142D 3D TSV
US8673950 149 Dihydrooxazol-2-amine derivatives Hoffmann-LaRoche Inc. 09/08/142D 3D TSV
US8669380 8 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives Pfizer Inc. 09/08/142D 3D TSV
US8673905 42 Imidazo pyrazines Hoffmann-La Roche Inc. 09/08/142D 3D TSV
US8669252 14 Prolylcarboxypeptidase inhibitors Merck Sharp & Dohme Corp. 09/08/142D 3D TSV
US8669361 86 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use F. Hoffmann-La Roche AG 09/08/142D 3D TSV
US8669266 17 Quinoline-carboxamide derivatives as P2Y12 antagonists Sanofi 09/08/142D 3D TSV
US8673966 123 ALDH-2 inhibitors in the treatment of addiction Gilead Sciences, Inc. 09/03/142D 3D TSV
US8674113 185 Compounds Boehringer Ingelheim International GmbH 09/03/142D 3D TSV
US8653125 23 Cyclohexane derivative having NPY Y5 receptor antagonism Shionogi Co., Ltd. 09/03/142D 3D TSV
US8653263 733 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators Janssen Pharmaceutica 09/03/142D 3D TSV
US8674100 93 Inhibitors of C-FMS kinase Janssen Pharmaceutica, N.V. 09/03/142D 3D TSV
US8653111 20 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases Bayer Intellectual Property GmbH 09/03/142D 3D TSV
US8653092 188 Tetrahydro-pyrido-pyrimidine derivatives Novartis AG 09/03/142D 3D TSV
US8664236 35 1H-pyrrolo[2,3 b]-pyridine derivatives Merck Patent GmbH 08/26/142D 3D TSV
US8664219 26 Aminopyrimidines useful as inhibitors of protein kinases Vertex Pharmaceuticals Incorporated 08/26/142D 3D TSV
US8648092 144 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications MEI Pharma 08/26/142D 3D TSV
US8664258 5 Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto Arena Pharmaceuticals, Inc. 08/26/142D 3D TSV
US8653091 46 Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof Evotec AG 08/26/142D 3D TSV
US8653087 741 Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors Boehringer Ingelheim International GmbH 08/26/142D 3D TSV
US8664230 18 Pyridopyrimidine derivatives and use thereof The Asan Foundation 08/26/142D 3D TSV
US8637558 130 Thiazolidinedione derivative and use thereof Industry-Academic Cooperation Foundation, Chosun University 08/26/142D 3D TSV
US8637502 75 2,3,4,5-tetrahydro-benzo{B}{1,4}diazepine-comprising compounds of formula(III) for treating pain Purde Pharma L.P.; Shionogi & Co., Ltd. 08/22/142D 3D TSV
US8633183 1192 5-alkynyl-pyrimidines Boehringer Ingelheim International GmbH 08/22/142D 3D TSV
US8637532 1511 Amino azaheterocyclic carboxamides Merck Patent GmbH 08/22/142D 3D TSV
US8637500 360 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors Amgen Inc. 08/22/142D 3D TSV
US8637508 90 Heterocyclic derivatives and their use in the treatment of neurological disorders Novartis AG 08/22/142D 3D TSV
US8637526 40 Pyrazolopyrimidine JAK inhibitor compounds and methods Genentech, Inc. 08/22/142D 3D TSV
US8637504 37 Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity Shionogi & Co., Ltd. 08/22/142D 3D TSV
US8637528 8 Use of PDE7 inhibitors for the treatment of movement disorders Omeros Corporation 08/22/142D 3D TSV
US8633204 174 4-methylpyridopyrimidinone compounds Pfizer Inc. 08/06/142D 3D TSV
US8633208 48 6-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligands Rottapharm S.p.A 08/06/142D 3D TSV
US8633188 60 Aminodihydrothiazine derivatives Shionogi & Co., Ltd. 08/06/142D 3D TSV
US8637501 113 Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof Albany Molecular Research, Inc. 08/06/142D 3D TSV
US8633196 19 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics Galderma Research & Development 08/06/142D 3D TSV
US8637507 15 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase Merck Sharp & Dohme Corp. 08/06/142D 3D TSV
US8633212 166 Inhibitors of beta-secretase Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH 08/06/142D 3D TSV
US8633226 5 Piperidinyl derivative as a modulator of chemokine receptor activity Bristol-Myers Squibb Company 08/06/142D 3D TSV
US8633206 417 Pyrrolo[2,3-D]pyrimidine compounds Pfizer Inc. 08/06/142D 3D TSV
US8633231 20 Substituted imidazolones, compositions containing such compounds and methods of use Merck Sharp & Dohme Corp. 08/05/142D 3D TSV
US8629158 46 Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof Albany Molecular Research, Inc. 07/28/142D 3D TSV
US8623860 151 Azetidine derivatives, pharmaceutical compositions and uses thereof Boehringer Ingelheim International GmbH 07/28/142D 3D TSV
US8623863 24 Disubstituted azepan orexin receptor antagonists Merck Sharp & Dohme Corp. 07/28/142D 3D TSV
US8629282 13 Heterocyclic compounds as S1P1 agonists for the treatment of autoimmune and vascular diseases Bristol-Myers Squibb Company 07/28/142D 3D TSV
US8629135 14 Pharmaceutical compositions comprising RET inhibitors and methods for the treatment of cancer Queen's University at Kingston 07/28/142D 3D TSV
US8629167 93 Selective androgen receptor modulators Radius Health, Inc. 07/28/142D 3D TSV
US8628961 13 Small molecule antagonists of phosphatidylinositol-3,4,5-triphosphate (PIP3) and uses thereof Tufts University; Council of Scientific and Industrial Research 07/28/142D 3D TSV
US8629141 39 Spiro-oxindole MDM2 antagonists The Regents of the University of Michigan; Sanofi 07/28/142D 3D TSV
US8629154 10 Substituted cycloalcano[e and d] pyrazolo [1,5-a]pyrimidines/antagonists of serotonin 5-HT6 receptors and methods for production and the use thereof TBA 07/28/142D 3D TSV
US8623883 20 4-phenylamino-quinazolin-6-yl-amides Warner-Lambert Company LLC 07/22/142D 3D TSV
US8623865 3 Acylpiperazinones and their use as pharmaceuticals Fab Pharma S.A.S. 07/22/142D 3D TSV
US8623901 43 Compounds for the treatment of CNS disorders Boehringer Ingelheim International GmbH 07/22/142D 3D TSV
US8623885 48 Fused tricyclic dual inhibitors of CDK 4/6 and FLT3 Amgen Inc. 07/22/142D 3D TSV
US8618103 236 Inhibitors of JAK Hoffmann-La Roche Inc. 07/22/142D 3D TSV
US8623892 13 Metalloenzyme inhibitor compounds Viamet Pharmaceuticals, Inc. 07/22/142D 3D TSV
US8618107 64 Pyridone and aza-pyridone compounds and methods of use Gilead Connecticut, Inc.; Genentech, Inc. 07/22/142D 3D TSV
US8623889 490 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof Genentech, Inc. 07/22/142D 3D TSV
US8623906 70 Carboxy isatin hydrazones and their esters as Shp2 inhibitors H. Lee Moffitt Cancer Center and Research Institute, Inc. 07/21/142D 3D TSV
US8618114 79 Substituted 3-arylsulfonyl-pyrazolo[1,5-A]pyrimidines, serotonin 5-HT6 receptor antagonists and methods for the production and use thereof TBA 07/09/142D 3D TSV
US8618111 284 5-alkynyl-pyrimidines Boehringer Ingelheim International GmbH 07/08/142D 3D TSV
US8618286 87 Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity NeurAxon, Inc. 07/08/142D 3D TSV
US8618075 9 Certain compounds, compositions and methods Eisai Inc. 07/08/142D 3D TSV
US8623903 17 Indolecarboxylic acid derivative having PGD2 receptor antagonistic activity Shionogi & Co., Ltd. 07/08/142D 3D TSV
US8618098 4 Inhibitors of bruton's tyrosine kinase Roche Palo Alto LLC 07/08/142D 3D TSV
US8618147 16 Modified macrophage migration inhibitory factor inhibitors The Feinstein Institute for Medical Research 07/08/142D 3D TSV
US8624022 14 Substituted aniline derivatives UCB Pharma, S.A. 07/08/142D 3D TSV
US8618158 80 Therapeutic agents Cancer Research Technology Limited 07/08/142D 3D TSV
US8614253 302 IRE-1α inhibitors MannKind Corporation 06/25/142D 3D TSV
US8614234 165 Compounds as tyrosine kinase modulators Allergan, Inc. 06/24/142D 3D TSV
US8618290 17 HSP90 inhibitors Takeda Pharmaceutical Company Limited 06/24/142D 3D TSV
US8613914 197 Peptidomimetic sulfamide compounds and antiviral uses thereof Novartis AG 06/24/142D 3D TSV
US8614206 289 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use F. Hoffmann-La Roche AG 06/24/142D 3D TSV
US8614215 103 Quinoxaline inhibitors of phosphoinositide-3-kinases (PI3Ks) Merck Serono SA 06/24/142D 3D TSV
US8618299 55 Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof Albany Molecular Research, Inc. 06/16/142D 3D TSV
US8609647 91 Nitrogen-containing spirocyclic compounds and pharmaceutical uses thereof Japan Tobacco Inc. 06/16/142D 3D TSV
US8618303 36 Pyrrolidine derivatives Hoffmann-La Roche Inc. 06/16/142D 3D TSV
US8609678 365 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof Acetylon Pharmaceuticals 06/16/142D 3D TSV
US8609681 72 Spirocyclic nitriles as protease inhibitors Sanofi 06/16/142D 3D TSV
US8609708 141 Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer Human BioMolecular Research Institute 06/16/142D 3D TSV
US8604061 221 2-aminooxazolines as TAAR1 ligands Hoffmann-La Roche Inc. 06/04/142D 3D TSV
US8609666 67 2-morpholino-pyrido[3,2-D]pyrimidines Merck Serono SA 06/04/142D 3D TSV
US8609622 20 C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof Shanghai Hengrui Pharmaceutical Co., Ltd.; Jiangsu Hengrui Medicine Co., Ltd. 06/04/142D 3D TSV
US8609710 29 Cycloalkyl-substituted imidazole derivative Daiichi Sankyo Company, Limited 06/04/142D 3D TSV
US8609715 258 Heteroarylcarboxylic acid ester derivative Ajinomoto Co., Inc. 06/04/142D 3D TSV
US8609698 8 Substituted dipyridyl-dihydropyrazolones and use thereof Bayer Intellectual Property GmbH 06/04/142D 3D TSV
US8604028 6 Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof Bayer Intellectual Property GmbH 05/13/142D 3D TSV
US8609852 103 Thiazolyl mGluR5 antagonists and methods for their use Merck Sharp & Dohme Corp. 05/13/142D 3D TSV
US8604206 18 Compositions for preventing and/or treating degenerative disorders of the central nervous system Amicus Therapeutics, Inc. 05/12/142D 3D TSV
US8604016 694 Heterocyclic inhibitors of glutaminase Calithera Biosciences Inc. 05/12/142D 3D TSV
US8609688 36 Substituted imidazopyridinyl-aminopyridine compounds ArQule, Inc. 05/12/142D 3D TSV
US8604217 78 Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent Selvita S.A. 05/05/142D 3D TSV
US8609892 2 Glucagon receptor antagonists, preparation and therapeutic uses Eli Lilly and Company 05/05/142D 3D TSV
US8598119 47 Methods and compositions for sleep disorders and other disorders Intra-Cellular Therapies, Inc. 05/05/142D 3D TSV
US8609833 18 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof Inotek Pharmaceuticals Corporation 05/05/142D 3D TSV
US8604046 69 Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof Sanofi 05/05/142D 3D TSV
US8598157 90 5-alkynyl-pyridines Boehringer Ingelheim International GmbH 04/28/142D 3D TSV
US8598163 45 Derivatives of [1,3]Oxazin-2-one useful for the treatment of metabolic diseases such as lipid disorders Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH 04/28/142D 3D TSV
US8598184 5 Protein kinase inhibitors Tiger Pharmatech 04/28/142D 3D TSV
US8598172 6 Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors Nerviano Medical Sciences S.r.l. 04/28/142D 3D TSV
US8598206 241 Trypsin-like serine protease inhibitors, and their preparation and use The Medicines Company (Leipzig) GmbH 04/28/142D 3D TSV
US8604218 166 Cytoskeletal active rho kinase inhibitor compounds, composition and use Inspire Pharmaceuticals, Inc. 04/18/142D 3D TSV
US8598155 86 Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders Pfizer Inc. 04/18/142D 3D TSV
US8598217 20 Imidazole derivatives and their use as modulators of cyclin dependent kinases Astex Therapeutics Ltd.; Novartis AG 04/18/142D 3D TSV
US8598200 29 KAT II inhibitors Pfizer Inc. 04/18/142D 3D TSV
US8598210 55 Prolyl hydroxylase inhibitors and methods of use Akebia Therapeutics, Inc. 04/18/142D 3D TSV
US8592371 8 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Merck Sharpe & Dohme Corp. 04/14/142D 3D TSV
US8592426 124 Aryl-benzocycloalkyl amide derivatives Hoffmann—La Roche Inc. 04/14/142D 3D TSV
US8598357 237 Benzodioxole piperidine compounds Hoffmann-La Roche Inc. 04/14/142D 3D TSV
US8592432 61 Compounds and compositions as protein kinase inhibitors TBA 04/14/142D 3D TSV
US8592410 135 Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1 Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH 04/14/142D 3D TSV
US8575157 341 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International, GmbH 04/14/142D 3D TSV
US8592431 151 Fused ring compound and use thereof Takeda Pharmaceutical Company Limited 04/14/142D 3D TSV
US8592425 5 Imidazo[1,2-a]pyridines and imidazo[1,2-b]pyridazines as mark inhibitors Merck Sharp & Dohme Corp. 04/14/142D 3D TSV
US8592423 3 Inhibitors of PDE10 Bristol-Myers Squibb Company 04/14/142D 3D TSV
US8592379 11 Metastin derivative and use thereof Kyoto University; Takeda Pharmaceutical Company Limited 04/14/142D 3D TSV
US8592415 144 Selective kinase inhibitors Reaction Biology Corp.; Synerga Limited 04/14/142D 3D TSV
US8598345 91 Substituted heteroarylamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same Vanderbilt University 04/14/142D 3D TSV
US8592468 14 Bacterial thioredoxin reductase inhibitors and methods for use thereof Thioredoxin Systems AB 03/17/142D 3D TSV
US8592457 5 Isonicotinamide orexin receptor antagonists Merck Sharp & Dohme Corp. 03/17/142D 3D TSV
US8592455 417 Kinase inhibitors and methods of their use Novartis AG 03/17/142D 3D TSV
US8592454 32 Nitrogen-containing heterocyclic compound and use of same Takeda Pharmaceutical Company Limited 03/17/142D 3D TSV
US8592579 45 Pyrrolotriazine kinase inhibitors Bristol-Myers Squibb Company 03/17/142D 3D TSV
US8592581 36 Trisubstituted purine derivatives Cyclacel Limited; Cancer Research Technology Limited 03/17/142D 3D TSV
US8586580 8 2,7-substituted thieno[3,2-d] pyrimidine compounds as protein kinase inhibitors Korea Institute of Science and Technology 03/12/142D 3D TSV
US8586617 104 Aminomethyl-4-imidazoles Hoffmann-La Roche Inc. 03/12/142D 3D TSV
US8586579 423 Anellated pyridine compounds Hoffmann-La Roche Inc. 03/12/142D 3D TSV
US8586571 15 Heterocyclic compound Takeda Pharmaceutical Company Limited 03/12/142D 3D TSV
US8586600 34 Heterocyclic compounds and uses thereof Celgene Avilomics Research, Inc. 03/12/142D 3D TSV
US8586620 134 Substituted indole compounds having NOS inhibitory activity NeurAxon, Inc. 03/12/142D 3D TSV
US8580800 9 1,4-diaryl-pyrimidopyridazine-2,5-diones and their use Bayer Intellectual Property GmbH 03/06/142D 3D TSV
US8586597 5 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta ICOS Corporation 03/06/142D 3D TSV
US8575203 258 Chemical compounds Boehringer Ingelheim International GmbH 03/06/142D 3D TSV
US8580788 21 Opioid antagonists Adolor Corporation 03/06/142D 3D TSV
US8575197 752 Pyrolinone derivative and pharmaceutical composition comprising the same Shionogi & Co., Ltd. 03/06/142D 3D TSV
US8580778 9 Substituted dihydropyrazolones and their use Bayer Intellectual Property GmbH 03/06/142D 3D TSV
US8580782 16 Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors Merck Sharp & Dohme Corp. 03/06/142D 3D TSV
US8575391 31 5-substituted-2-phenylamino benzamides as MEK inhibitors Chugai Seiyaku Kabushiki Kaisha 02/24/142D 3D TSV
US8575375 5 Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties Research Triangle Institute; The United States of America, as represented by the Secretary, Department of Health and Human Services 02/24/142D 3D TSV
US8569291 11 Bicyclic dihydroimidazolone CGRP receptor antagonists Merck Sharp & Dohme Corp. 02/24/142D 3D TSV
US8569281 119 Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRK Medical Research Council Technology; Genentech, Inc. 02/24/142D 3D TSV
US8580815 16 Derivatives of azaindoles as inhibitors of protein kinases ABL and SRC Oribase Pharma 02/24/142D 3D TSV
US8575186 219 Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof Albany Molecular Research, Inc. 02/24/142D 3D TSV
US8569306 18 JNK modulators Hoffmann-La Roche, Inc. 02/24/142D 3D TSV
US8569313 47 Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors The Medicines Company (Leipzig) GmbH 02/24/142D 3D TSV
US8575364 66 Modulators of serotonin receptor Janssen Pharmaceutica NV 02/24/142D 3D TSV
US8575201 175 Oxadiazole inhibitors of leukotriene production Boehringer Ingelheim International GmbH 02/24/142D 3D TSV
US8569299 10 Prolylcarboxypeptidase inhibitors Merck Sharp & Dohme Corp 02/24/142D 3D TSV
US8569311 48 Pyridyl piperidine orexin receptor antagonists Merch Sharp & Dohme Corp. 02/24/142D 3D TSV
US8569316 64 Pyrimido [5,4-D] pyrimidine derivatives for the inhibition of tyrosine kinases Boehringer Ingelheim International GmbH 02/24/142D 3D TSV
USRE44599 5 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta ICOS Corporation 02/24/142D 3D TSV
US8575114 43 SGLT-2 inhibitors, methods of making them, and uses thereof Albany Molecular Research, Inc. 02/24/142D 3D TSV
US8569308 118 Substituted heteroarylamine carboxamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same Vanderbilt University 02/24/142D 3D TSV
US8569314 10 Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPD Bayer Intellectual Property GmbH 02/24/142D 3D TSV
US8575145 329 Triazolopyridine compounds as PIM kinase inhibitors Array BioPharma Inc. 02/24/142D 3D TSV
US8569521 10 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors Merck Sharp & Dohme Corp. 01/21/142D 3D TSV
US8569318 7 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof TBA 01/21/142D 3D TSV
US8569338 3 Methods of using 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine compounds Proximagen Ltd. 01/20/142D 3D TSV
US8563583 6 Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists Bristol-Myers Squibb Company 01/20/142D 3D TSV
US8569511 40 Substituted 3-(1H-benzo[d]imidazol-2-yl)-1H-indazole analogs as inhibitors of the PDK1 kinase University of Utah Research Foundation 01/20/142D 3D TSV
US8562945 22 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof Molecular Insight Pharmaceuticals, Inc. 01/20/142D 3D TSV
US8551988 144 Benzimidazole derivatives: preparation and pharmaceutical applications Mei Pharma, Inc. 01/14/142D 3D TSV
US8563545 42 Compound useful for the treatment of degenerative and inflammatory diseases Galapagos NV 01/14/142D 3D TSV
US8563553 103 Compounds and compositions as protein kinase inhibitors Novartis AG; IRM LLC 01/14/142D 3D TSV
US8551978 95 Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity Theravance, Inc. 01/14/142D 3D TSV
US8551963 10 Imidazolothiazole compounds and methods of use thereof Ambit Biosciences Corporation 01/14/142D 3D TSV
US8563594 17 S1P3 receptor inhibitors for treating pain Allergan, Inc. 01/14/142D 3D TSV
US8552005 16 (EN) 3-sulfonyl-pyrazolo[1,5-a] pyrimidines / antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof Avincuro Pharmaceuticals, Inc. 01/03/142D 3D TSV
US8552017 4 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-A]pyrido-pyrimidine antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof TBA 01/03/142D 3D TSV
US8552004 30 Chemical compounds AstraZeneca AB 01/03/142D 3D TSV
US8546370 24 Compounds and compositions as kinase inhibitors IRM LLC 01/03/142D 3D TSV
US8552023 5 Non-amidic linkers with branched termini as CGRP receptor antagonists Merck Sharp & Dohme Corp. 01/03/142D 3D TSV
US8551989 12 Substituted 4-(indazolyl)-1,4-dihydropyridines and methods of use thereof Bayer Intellectual Property GmbH 01/03/142D 3D TSV
US8546380 61 Aminodihydrothiazine derivatives Shionogi & Co., Ltd. 12/22/132D 3D TSV
US8552202 105 Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitors Amura Therapeutics Limited 12/22/132D 3D TSV
US8552033 2 Inhibitors of CXCR2 SANOFI 12/22/132D 3D TSV
US8552057 12 Phytoestrogenic formulations for alleviation or prevention of neurodegenerative diseases University of Southern California 12/22/132D 3D TSV
US8552037 42 Tricyclic compound and pharmaceutical use thereof Takeda Pharmaceutical Company Limited 12/22/132D 3D TSV
US8546392 59 17Beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases Universitaet des Saarlandes 12/09/132D 3D TSV
US8546404 17 Compounds that are ERK inhibitors Merck Sharp & Dohme 12/09/132D 3D TSV
US8552199 24 Substituted indanes, method for the production thereof, and use thereof as drugs Sanofi 12/09/132D 3D TSV
US8546434 14 Triazole compounds as KSP inhibitors Novartis AG 12/09/132D 3D TSV
US8546389 76 Viral polymerase inhibitors Biota Scientific Management Pty Ltd. 12/09/132D 3D TSV
US8541380 97 C-aryl glucoside SGLT2 inhibitors and pharmaceutical compositions comprising same Green Cross Corporation 12/03/132D 3D TSV
US8546451 20 Estrogen receptor ligands and methods of use thereof GTx, Inc. 12/03/132D 3D TSV
US8541363 4 Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use St George's Hosptial Medical School; The University of Manchester 12/03/132D 3D TSV
US8541407 230 Substituted benzo-pyrido-triazolo-diazepine compounds ArQule, Inc. 12/03/132D 3D TSV
US8546435 9 Triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II 12/03/132D 3D TSV
US8541447 6 3-substituted-2-(arlyalkyl)-1-azabicycloalkanes and methods of use thereof Targacept, Inc. 11/26/132D 3D TSV
US8541408 48 Aminodihydrothiazine derivatives substituted with a cyclic group Shionogi & Co., Ltd. 11/26/132D 3D TSV
US8541572 292 Compounds for the treatment of inflammatory disorders Merck Sharp & Dohme Corp. 11/26/132D 3D TSV
US8541596 10 Inhibitors Probiodrug AG 11/26/132D 3D TSV
US8541427 45 Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use Merck, Sharp & Dohme, Corp. 11/26/132D 3D TSV
US8536165 55 Azabiphenylaminobenzoic acid derivatives as DHODH inhibitors Almirall, S.A. 11/18/132D 3D TSV
US8536158 8 Compounds having CRTH2 antagonist activity Atopix Therapeutics Limited 11/18/132D 3D TSV
US8536166 4 Inhibitors of Burton's tyrosine kinase Roche Palo Alto LLC 11/18/132D 3D TSV
US8536172 106 Inhibitors of JNK Roche Palo Alto LLC 11/18/132D 3D TSV
US8536175 50 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors Novartis AG 11/18/132D 3D TSV
US8536173 10 Tetrahydroquinoxaline urea derivatives as modulators of 11-B-hydroxysteroid dehydrogenase type I SANOFI 11/18/132D 3D TSV
US8536192 53 6,7-unsaturated-7-carbamoyl substituted morphinan derivative Shionogi & Co. Ltd. 11/11/132D 3D TSV
US8536210 19 Compounds for inhibiting semicarbazide-sensitive amine oxidase (SSAO)/vascular adhesion protein-1 (VAP-1) and uses thereof for treatment and prevention of diseases Semmelweis Egyetem 11/11/132D 3D TSV
US8536193 14 Inhibitors of AKT activity Merck Sharp & Dohme Corp.; MSD K.K. 11/11/132D 3D TSV
US8536198 23 Piperidine derivatives as modulators of chemokine receptor activity Bristol-Myers Squibb Company 11/11/132D 3D TSV
US8536181 32 Prolyl hydroxylase inhibitors Aerpio Therapeutics Inc. 11/11/132D 3D TSV
US8530460 200 Azetidine derivatives Boehringer Ingelheim International GmbH 11/04/132D 3D TSV
US8530648 404 Diaza-spiro[5.5]undecanes Novartis AG 11/04/132D 3D TSV
US8536227 10 Modulators of protein kinase signaling Novotyr Therapeutics Ltd. 11/04/132D 3D TSV
US8530504 83 Pyrazolothiazole compound Eisai R&D Management Co., Ltd. 11/04/132D 3D TSV
US8530490 143 Uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity Taiho Pharmaceutical Co., Ltd. 11/04/132D 3D TSV
US8530494 94 Buprenophine analogs Purdue Pharma LP 10/25/132D 3D TSV
US8530670 5 Inhibitors Probiodrug AG 10/25/132D 3D TSV
US8524716 27 Macrocyclic indoles as hepatitis C virus inhibitors Janssen R&D Ireland 10/25/132D 3D TSV
US8524710 86 Pyrrolidine derivatives Hoffmann-La Roche Inc. 10/25/132D 3D TSV
US8530652 86 Pyrrolopyrazoles, potent kinase inhibitors Agouron Pharmaceuticals, Inc.; Pfizer Inc. 10/25/132D 3D TSV
US8524699 11 Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitors Bayer Intellectual Property GmbH 10/25/132D 3D TSV
US8507477 10 3- and 6-quinolines with N-attached heterocyclic CGRP receptor antagonists Merck, Sharp & Dohme, Corp. 10/18/132D 3D TSV
US8524917 157 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity Allergan, Inc. 10/18/132D 3D TSV
US8507479 48 Aminodihydrothiazine derivatives substituted with a cyclic group Shionogi & Co., Ltd. 10/18/132D 3D TSV
US8524717 175 Oxidase inhibitors and their use Oryzon Genomics, S.A. 10/18/132D 3D TSV
US8524722 21 Substituted tricyclic compounds and methods of use thereof Bayer Intellectual Property GmbH 10/18/132D 3D TSV
US8507510 190 Sulfoximine-substituted pyrimidines as CDK- and/or VEGF inhibitors, their production and use as pharmaceutical agents Bayer Intellectual Property GmbH 10/18/132D 3D TSV
US8524909 65 Tetrahydro-pyran derivatives Hoffmann-La Roche Inc. 10/18/132D 3D TSV
US8507714 18 7-membered ring compound and method of production and pharmaceutical application thereof Daiichi Sankyo Company, Limited 10/07/132D 3D TSV
US8501732 211 Aminomethyl quinolone compounds Hoffmann-La Roche Inc. 10/07/132D 3D TSV
US8507683 7 Compounds for the treatment of hepatitis C Bristol-Myers Squibb Company 10/07/132D 3D TSV
US8507533 84 Glucagon receptor modulators Pfizer Inc. 10/07/132D 3D TSV
US8507676 92 Heterocyclic oxime compounds Novartis AG 10/07/132D 3D TSV
US8507535 25 Methyl-pyrrolidine ether derivatives Hoffmann-La Roche Inc. 10/07/132D 3D TSV
US8501749 31 Azaquinazolinediones chymase inhibitors Boehringer Ingelheim International GmbH 09/30/132D 3D TSV
US8501981 6 CXCR2 inhibitors SANOFI 09/30/132D 3D TSV
US8501783 79 Conformationally restricted urea inhibitors of soluble epoxide hydrolase The Regents of the University of California 09/30/132D 3D TSV
US8501944 20 Inhibitors of protein kinases Portola Pharmaceuticals, Inc. 09/30/132D 3D TSV
US8501744 22 Piperazine compounds Amura Therapeutics, Limited 09/30/132D 3D TSV
US8501729 34 5-HT3 receptor modulators, methods of making, and use thereof Albany Molecular Research, Inc. 09/16/132D 3D TSV
US8501961 20 HIV protease inhibitors and methods for using Purdue Research Foundation 09/16/132D 3D TSV
US8501750 52 Heterocyclic compound and use thereof Takeda Pharmaceutical Company Limited 09/16/132D 3D TSV